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DNA synthesis in gametocytes takes place at two points; at the onset of
gametocytogenesis where the nucleic acid content increases from lc to 1.8c prior to the
formation of stage I gametocytes, and again 10 to 12 days later at the onset of
gametogenesis when the mature male gametocyte (stage V) replicates its genome three
times leading to the formation of eight haploid male gametes in less than 10 minutes.
The aim of this study was to evaluate the status of the P. falciparum DNA replication
apparatus during gametocytogenesis, most of which no significant DNA synthesis takes
place, and gametogenesis in which a sudden burst of DNA replication takes place. The
proteins studied in this project were DNA topoisomerase 1 and 11 (Topol and II),
Replication factor C (Rfc) and Proliferating cell nuclear antigen (Pcna) of which P.
falciparum homologous have been previously identified, isolated and characterised.
Standard indirect immunofluorescence assays (IFA) carried out on unsynchronised in
vitro cultivated P. falciparum (3D7A) using rabbit polyclonal antiserum raised against
recombinant PfRfcl, PfRfc2, PfRfc3, PfPcna and PfTopoII showed that all five
proteins are present throughout gametocytogenesis. All five proteins appear to be
predominantly located within the nuclear region and at significantly higher levels in
stage I and V gametocytes. However PfRfc2 levels appeared to be significantly higher
only in stage I gametocytes and was distinctly absent from the nucleus of stage V
gametocytes. Western blot analysis showed no significant changes in the levels of these
proteins occurred during gametogenesis, with the exception of PfRfc2, which appear to
increase immediately after activation and then gradually decrease as gametogenesis
progressed.
RT-PCR detected the presence of PfRFC2, PARFC3, PfPCNA, PfDNA POL5 and
PiTOPO 1 transcripts in mature gametocytes before and after activation. However,
PfRFCl and PfTOPO II transcripts were not detected in mature gametocytes either
before or after activation. Similar results in protein and RNA analysis were obtained
whether gametocytes were grown in AlbuMax or serum supplemented medium. In situ
hybridisation using fluorescein-labelled PfRFCl, PfRFC2, PfDNA POL8, PfTOPO 1 and
PfTOPO II gene fragments showed pockets of fluorescence on the peripheral regions of
schizonts away from the nuclear region stained by DAPI. PfRFC3 and PfPCNA probes
appeared to show fluorescence emanating from the nuclear region of schizonts.
In conclusion, the localisation and unique expression pattern of PfRfc2 observed before
and during gametogenesis, from that of the other DNA replication proteins and in
particular, PfRfcl and PfRfc3, appears to imply a significant role for PfRfc2. Further
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CHAPTER 1
INTRODUCTION AND LITERATURE REVIEW
1
1.1 Malaria
1.1.1 Malaria the disease
Malaria is an infectious disease caused by parasitic protozoa of the genus
Plasmodium and is transmitted to the human host through the bite of an infected
female Anopheles mosquito. There are many species of Plasmodium, some of which
infect reptiles, birds, rodents, and primates. There are four species of Plasmodium
that infect man; P. falciparum, P. vivax, P. malariae, and P. ovale. P. falciparum is
the most widely distributed in the world and also the most virulent species of
Plasmodium. It is potentially lethal to humans because it causes the most dangerous
complications, such as encephalopathy, renal failure and severe haemolytic anaemia
leading to coma and death within a few days.
The vast majority ofP. falciparum malaria occurs in sub-Saharan Africa. 300 to 500
million new infections and 2 to 4 million deaths annually attributed to malaria occur
in residents of malaria endemic countries, the majority in sub-Saharan Africa alone
where it is estimated that 90% of the infected people live (WHO, 1994; Anon, 1996).
The primary population at risk is young children in sub-Saharan Africa. In western
Kenya, for example, greater than 95% of children under the age of 5 years have
parasites in their bloodstream during much of the year and an estimated 26,000
children die of malaria in Kenya every year which translates to 72 deaths a day
(Snowe/ur/., 1999). Across the whole of Africa alone, refined figures suggest that a
fraction under a million people died of malaria in 1995, of which 750,000 were
children (Bloland et al., 1996). Pregnant women are also at risk since the disease is
responsible for a substantial number of miscarriages and low birth weight babies. P.
vivax is also a common cause of human malaria, especially in South East Asia and in
Central and South America. Though P. vivax rarely causes death, some patients with
this form of malaria may develop severe clinical symptoms like anaemia (Tan-ariya et
al., 1996).
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1.1.2 Malaria in history
Malaria is probably older than man is, so human Plasmodium species must have
evolved with man in Africa and spread with human migration into Europe, the
Middle East, Asia, India and China. The wide distribution of malaria is attributed to
the adaptability and breeding of the Anopheles mosquito. Malaria control was
practised long before the parasite was discovered. The Greeks and the Romans in
classical times recommended that houses should be built in dry and elevated
positions in order to avoid fever, and also the health benefits of draining marshes
were known. Rome itself is a city on hills surrounded by the former marshes of the
Campagna which were infested by mosquitoes that spread malaria to unsuspecting
armies camped outside Rome and waiting to attack. Indeed, 'Mai'aria' means 'bad
air' in Italian. It arose from the belief that malaria came from putrid air above
stagnant water. It was not until 1880, that Alphonse Laveran, a young doctor in the
French Army in Constantine, Algeria, discovered tiny microscopic parasites in the
red blood cells of malaria patients and directly attributed them to being the cause of
malaria. In 1897, Ronald Ross a Surgeon Major in the Indian Army in Secunderabad,
India, found malaria parasites in mosquitoes. Ross declared that mosquitoes transmit
malaria and received the Nobel Prize in 1902. It was after Ross's discovery of role
mosquitoes in malaria transmission that malaria epidemiology became a science.
Ross went on to make practical studies ofmalaria control and began the mathematical
analysis of malaria transmission (Bruce-Chwatt, 1985).
1.1.3 Malaria eradication and control
In 1955, the Eighth World Health Assembly announced a programme for global
malaria eradication. The eradication programmes were initiated in all malarious
countries in the Americas and Europe, and in a majority of countries in Asia and
Oceania. Only pilot projects were attempted in Africa. By 1970, malaria had been
eliminated from the whole of North America, Europe, parts of Asia and South
America, and several countries in the Middle East; this regions had 727 million
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people now freed from malaria, and represented 53% of the originally malarious areas
(Gilles and Warrell, 1995). However, seasonal and endemic malaria remained
unchanged in tropical Africa where there was hardly any significant implementation
of the malaria eradication programme. In 1969, the Malaria Eradication Programme
was converted into a Malaria Control Program and consequently, the malaria
situation greatly deteriorated. The resurgence of the disease affected several
countries in southern Asia and Latin America and the number of reported cases of
malaria (excluding Africa) had more than doubled by 1977. This was attributed to
the reduction of malaria control activities in many countries as a result of the sudden
withdrawal of external resources, which was then aggravated by the energy crisis
during the 1970s and the subsequent economic strain felt by several countries.
Resurgence of malaria was also due to an increase in parasite drug resistance, the
rising costs of insecticides and the rapid increase in mosquito resistance to
insecticides such as DDT and other organophosphates (Gilles and Warrell, 1995).
1.1.4 Malaria vaccines
The development of vaccines against malaria presents formidable obstacles in terms
of parasite biology, mainly the immunogenicity and antigenic variability of some
malarial antigens, combined with the fact that some host immune response are
genetically restricted to certain parasite epitopes (Good et ah, 1998; Good and
Doolan, 1999). The introduction of DNA vaccine technology has facilitated an
unprecedented multi-antigen approach to developing an effective vaccine against P.
falciparum (Watts and Kennedy, 1999). Though clinical trials of DNA vaccines in
healthy human volunteers have shown them to be safe and well tolerated at all doses,
the frequency and magnitude of the immune response they elicit was found to be
suboptimal (Le et al., 2000). Considerable research efforts are now geared towards
immune enhancement strategies to improve DNA vaccines; such as the prime/boost
immunisation method where the immune system is primed with a DNA vaccine and
boosted with poxvirus or recombinant protein in the adjuvant. The prime/boost
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strategy administered in the right order, leads to very high levels of antigen-specific
cytotoxic T cells. In parallel, malaria vaccine research aims to capitalise on the data
obtained from the malaria genome project (Gardener et al., 1998) coupled with the
recent advances in gene expression, proteomics and molecular immunology
technologies (Hoffman et al., 2000; Hoffmann, 2000; Carucci, 2001) to come up with
a multi-valent, multi-stage and multi-immune response vaccine. Such a vaccine will,
hopefully, provide high-level, long-term, sustainable protection against malaria
parasites (Doolan and Hoffman, 2001).
1.1.5 Malarial chemotherapy
The spread of drug-resistant strains of P. falciparum since the 1960s is a major
public health challenge and the principal reason for the erosion of efficacious
treatments. The efficacy of chloroquine, which for several decades was a cheap,
highly effective, convenient, and relatively safe drug for the chemoprophylaxis and
treatment of malaria, has reduced dramatically (Gosh et al, 1992). The widespread
use of antimalarial drugs for prophylaxis with the inevitably poor compliance and
resulting underdosing has provided the selection pressure for the emergence of drug
resistance parasites. Cost and the limited number of antimalarial drugs in current use
impose considerable constraints on malaria control, especially in sub-Saharan Africa.
In addition, of the new antimalarial drugs available, none match the safety, breadth of
activity and speed of action exhibited by chloroquine when it was first introduced in
the 1940s. It is against this background that the need to identify new
chemotherapeutic targets in order to stop the proliferation and spread of malaria has
gathered momentum over the past 20 years. Hope now lies on the multidisciplinary
research on artemisinin-based combination therapy, which offers a new and
potentially highly effective way to prevent or retard the development of drug
resistance (Price et al., 1996).
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1.2 Plasmodium falciparum
1.2.1 Life cycle of P. falciparum
Plasmodium has a split life cycle, one in the human host and another in the female
Anopheles mosquito. The entire life cycle can be better understood as a sequence of
four phases: three asexual phases with multiplication and one sexual phase without
multiplication (Figure 1.1).
1.2.1.1 Hepatic schizogony
Infection begins when haploid sporozoites in the salivary glands of an infected female
Anopheles mosquito are inoculated into the bloodstream of the mammalian host
during the feeding of the mosquito. The sporozoites remain in the blood for about 30
minutes during which time many are destroyed by phagocytes. However, some
sporozoites invade the liver parenchymal cells and each transform into a round
hepatic trophozoite. This is the second growth form of the parasite. Within the
warm and nutrient-rich hepatocyte, the trophozoite grows rapidly distending and
destroying the host cell as it enlarges. The hepatic trophozoite undergoes multiple
cell divisions in a process known as pre-erythrocytic or hepatic schizogony and
becomes a multinucleated hepatic schizont. After 6 to 16 days from the time of
infection, the hepatic schizont bursts, releasing 10-30,000 invasive merozoites
embedded in fragments of degenerate cytoplasm into the surrounding tissue and
thence into the blood circulation. The masses are too large to be engulfed by Kupffer
cells and presumably disintegrate after leaving the liver, freeing the merozoites. Until
this time, the infected person has no symptoms and is unaware that infection is
progressing. This is called the incubation period of infection and includes the whole
of hepatic schizogony and the first few cycles of erythrocytic schizogony.
Some sporozoites of Plasmodium vivax upon invading liver hepatocytes do not
develop immediately but instead become tiny dormant parasites called hypnozoites.
These delay development for months or a few years and when they resume
development cause the delayed relapses typical of vivax malaria. P. malariae may
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also cause relapses sometimes twenty years after the first infection, but the resting
form of this species remains obscure.
1.2.1.2 Erythrocytic schizogony
The merozoites are the smallest and shortest-lived form in the life cycle. Upon
release, they immediately invade circulating red blood cells (erythrocytes) and
develop into small circular forms known as rings. Antibodies present in the blood of
partially immune individuals may, at this point, prevent invasion of the erythrocytes
by the merozoites by causing mature merozoites to cluster. Each ring-form of the
parasite grows in size as it ingests erythrocyte haemoglobin and cytoplasm,
becoming irregular in shape when it is referred to as an erythrocytic trophozoite, the
third growth form of the parasite. As haemoglobin is digested, an iron-haem pigment
called haemozoin (often referred to as 'malaria pigment') accumulates in food
vacuoles in the form of crystals. After 30-40 hours of growth, the trophozoite
undergoes multiple cell divisions resulting in the formation of an intraerythrocytic
schizont comprising between 8-32 merozoites in a process referred to as
intraerythrocytic schizogony. The schizont bursts releasing the merozoites into the
blood stream which then invade new erythrocytes and begin another cycle. This
erythrocytic cycle of schizogony is repeated several times in the course of an
infection, leading to progressive increase of parasitemia, hence illness, until the
process is slowed down by the immune response of the host. It is these repeated
asexual cycles in the blood that cause the relapsing fevers unique to malaria. The
fever are induced by pyrogens released during the rupture of schizonts and are
thought to cause transient suppression of the host immunity at the time of merozoite
release, the period at which the parasite is most vulnerable to the host defences
(Gilles and Warrell, 1995). After several asexual cycles, some merozoites invade
erythrocytes and develop into either male or female sexual forms (gametocytes).
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1.2.1.3 The sexual phase
The gametocytes, in the human host, take between 8-10 days to mature, a process
known as gametocytogenesis. The mature gametocytes taken up by a feeding
anopheline mosquito, are the only parasite forms able to survive in the mosquito
midgut. Within the mosquito midgut, both male (micro-) and female (macro-)
gametocytes transform into gametes and emerge from the erythrocytes. The male
parasites undergo rapid and repeated DNA replication to form eight haploid
microgametes and show violent internal activity, as up to 8 'flagella' form within
each cell and start to beat. As the formation of the flagella is completed their motion
tears the cell apart, releasing them into the plasma of the blood meal. Each flagellum
has a nucleus attached and swims in search of female gametes, which upon
fertilisation transform into zygotes. The newly formed diploid zygote undergoes
immediate meiotic division to re-establish the haploid genome (Sinden and Hartley,
1985; Sinden et al., 1985; Ranford-Cartwright et al., 1993). The zygote matures in
the next few hours into a motile ookinete. The ookinete is a motile form, which
glides through the blood meal until it reaches the stomach wall, where it passes
between or through the epithelial cells to reach the basement membrane. Here it
rounds up, loses the features of an invasive form, the apical complex, and transforms
into an oocyst and the next phase of sporogony begins. Sexual development within
the mosquito is completed quickly, in about 30 minutes. This presumably protects
the parasite from the lethal mosquito proteases that are secreted into the blood as
early as 5 hours after feeding (Briegel and Lea, 1975).
1.2.1.4 Sporogony
The oocyst, enclosed in a cyst wall formed of proteins secreted by the parasite and
the basement membrane of the epithelial cells, grows rapidly and projects into the
body cavity (haemocoel) of the mosquito. When mature, the oocyst is spherical, has
a diameter of 80 microns and can be seen with a dissecting microscope. The
developing oocyst feeds on haemoglobin in the blood meal and accumulates the black
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malaria pigment, also seen in erythrocytic trophozoites. After about seven days or
more (depending on the ambient temperature), the oocyst begins a process of internal
division, with the formation of thousands of worm-shaped sporozoites, the next
invasive form in the life cycle. The oocyst bursts fourteen or more days after
infection of the mosquito and the sporozoites migrate through the haemocoel and
invade the salivary glands. When the mosquito feeds again on a human host, she
injects saliva, containing sporozoites, into the blood. Within 30 minutes, the




The production of morphologically and physiologically mature P. falciparum
gametocytes takes 8-10 days in vivo (Smalley, 1977) and 14-23 days in vitro (Carter
and Beach, 1978) with identical morphological sequences during gametocytogenesis
(Hawking et al., 1971; Smalley, 1977; Jensen, 1979). The first definitive sign of
sexual differentiation of P. falciparum is the appearance, de novo, of sub-pellicular
cytoskeleton, that is, the inner pellicular membrane vesicle and microtubules (Sinden
and Smalley, 1979). The assembly and loss of these components of the cytoskeleton
cause gametocytes to acquire numerous characteristic changes in shape during
gametocytogenesis. Developing gametocyte-infected erythrocytes sequester from
the peripheral circulation to the blood spaces of the bone marrow and the spleen
(Garnham, 1966; Smalley et al., 1981). It is in these organs that gametocytes pass
through a series of fairly distinct morphological stages, categorised I-IV. This takes
8-10 days, after which 'mature' gametocytes are released into the circulation and,
after a further 2-3 days, become infectious to the mosquito (stage V).
Stage I gametocytes are round and difficult to distinguish from young trophozoites.
Stage II gametocytes, produced after two days of growth, are oat grain-shaped. A
new subpellicular cytoskeleton is laid down and subtended by a few microtubules
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and results in the formation of the stage III gametocytes that have a characteristic
elongated shape. It is at this point during gametocytogenesis (Stage III) that male and
female gametocytes can be distinguished from each other. The subpellicular
cytoskeleton completely encircles the gametocytes leading to the formation of
symmetrical stage IV gametocytes. Sexual dimorphism is further accentuated in stage
IV gametocytes, with a marked increase in the density of the ribosomes, endoplasmic
reticulum, Golgi vessels and mitochondria in the macrogametocyte relative to the
microgametocyte. This clearly reflects the subsequent development of the
macrogametocyte as an unfertilised egg. The collapse of the pointed spindle shape of
stage IV gametocytes leads to the formation of the crescent-shaped and
morphologically mature stage V gametocytes (Sinden, 1982).
Gametocytes are relatively metabolically inactive, a fact that renders many anti¬
malarial drugs ineffective. Although gametocytes do not directly cause any clinical
symptoms in humans, they are the clinical stages responsible for the continued
transmission of parasites from one vertebrate host to another via a complex sexual
life cycle in the mosquito vector. The process of sexual differentiation and
development therefore plays a central role in the life cycle of the human malaria
parasite.
1.3.2 Commitment to sexual differentiation
Factors that determine whether a merozoite differentiates into a sexual or asexual
parasite upon infecting an erythrocyte remain unclear. However, the progeny of an
individual schizont can either commit to asexual or sexual pathways upon re-
invasion. In order to get a better understanding of parasite differentiation, P.
falciparum schizonts, suitably diluted, were allowed to burst on monolayers of
immobilised uninfected erythrocytes in order to produce separated clusters of
synchronously growing sibling parasites and their development followed (Inselburg,
1983). This pioneering work by Inselburg (1983) observed, by morphological
examination, that cohorts of siblings from an individual schizont had a marked
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tendency to produce merozoites committed to the same developmental pathway,
either asexual or sexual. Later studies, using monoclonal antibodies to distinguish
between the developing sexual and asexual parasites, indicated that the progeny of
individual schizonts were labelled by only one or the other monoclonal antibody
(Bruce et al., 1990). The marked tendency observed by Inselburg was therefore an
absolute commitment of each schizont to produce a progeny of parasites with the
same developmental fate, developmental choice made in the parent schizont (Bruce et
al., 1990).
Gametocytes exist as male (microgametocytes) or female (macrogametocytes), the
precursors of male and female gametes, respectively. Until recently, gametocyte
sexes were only distinguishable by morphological examination of stage IV
gametocytes (Jensen, 1979). However, studies on gametocyte sex-specific gene
expression have shown that micro- and macrogametocytes of P. falciparum, each
express some proteins in a sex-specific manner. Microgametocytes express alpha-
tubulin II (Rawlings et al., 1992; Guinet et al., 1996), where it is proposed to have a
specific role in exflagellation and motility. Macrogametocytes express PJ77
transcripts (Baker et al., 1995) and, recently, the osmiophilic body protein, Pfg 377
(Severini et al., 1999). Antibodies against these sex-specific proteins are valuable
tools in the study of sexual dimorphism in P. falciparum.
Conditions for parasite growth on immobilised erythrocyte monolayers have been
improved to allow for the maturation of gametocytes to stage IV (Williams, 1999)
and recently, this method was used to address the question of sexual dimorphism;
analysing the sex of gametocytes arising from sexually committed clusters. The use
of gametocyte sex-specific markers, anti-Pfg377 and anti-alpha-tubulin II antisera, to
label clusters of stage IV gametocytes arising from individual schizonts of P.
falciparum, showed that individual schizonts commit to yield gametocytes of the
same sex (Silvestrini et al.,2000). These observations led Silvestrini et al., (2000) to
suggest that commitment to sexual differentiation and the sex of the resulting
gametocytes is determined prior to schizont maturation.
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1.3.3 Factors that influence commitment to sexual differentiation
It has been generally believed that stress plays a great part in the switch from asexual
replication to sexual differentiation of the parasite within the human host (Carter and
Miller, 1979). Gametocyte production can be seen as a survival mechanism, adopted
by the parasite, in response to retarded asexual growth in unfavourable conditions.
The proportion of parasites that develop into gametocytes varies greatly during the
course of natural infections in humans (Smalley et al., 1981; Magesa et al., 2000). In
vitro, high P. falciparum parasite densities have been a shown to lead to a high
proportion of merozoites transforming into gametocytes possibly due to the
decreasing availability of nutrients or the progressive fall in pH of the medium. The
addition or dilution of in vitro cultures of P. falciparum with fresh erythrocytes to
dramatically decreased the proportion of parasites that transform into gametocytes
(Carter and Graves, 1988). It has also been observed that in blood cultures of P.
falciparum, the conversion to gametocytes was stimulated by the presence of
lymphocytes and serum from individuals with acquired immunity to P. falciparum.
This observation suggests that the rate of conversion of asexual parasites to
gametocytes may be increased in immune individuals (Smalley and Brown, 1981).
Similar results were obtained with P. falciparum grown in culture medium to which
sera containing anti-malarial antibodies was added (Brockelman, 1979) or in a culture
medium supplemented with supernatants from hybridoma cell cultures containing
anti-malarial antibodies (Ono, et al., 1986). Anti-malarial drugs have also been shown
to increase gametocyte production; chloroquine-induced enhancement of gametocytes
production has been reported in vivo in P. chabaudi (Buckling et al., 1997) and in
vitro in P. falciparum (Buckling et al., 1999). This may help to explain the spread of
drug-resistant genotypes of P. falciparum.
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1.3.4 Genetic determinants of sexual differentiation
Experimental studies on the genetic determinants underlying gametocytogenesis have
taken account of two well-established features of this phenomenon. First, different
lines of parasites within a Plasmodium species differ markedly in their intrinsic
capacity to produce gametocytes. Secondly, parasite lines propagated exclusively by
asexual growth either in vitro or in vivo tend to progressively lose the capacity to
produce gametocytes (Walliker, 1976; Teklehaimanot, et al., 1987). Studies on
mutants defective in gametocyte production have shed some light on the control of
sexual differentiation in malaria parasites. Two Plasmodium chromosomes, 9 (Day et
al., 1993; Alano et al., 1995) and 12 (Viadya et al., 1995; Guinet et al., 1996; Guinet
and Wellems, 1997), have been identified as having putative genetic determinants
governing sexual development.
1.3.5 Sexual-stage-specific gene expression
A variety of proteins specific for sexual-stage parasites have been identified in avian,
rodent, and human malarias (Kaslow, 1990). Most of the research on the
identification of sexual-stage-specific proteins has been driven by the need to identify
novel targets for the induction of antibody-mediated transmission-blocking
immunity. Most of these proteins are differentially expressed in various sub-stages
of gametocyte development. In P. falciparum, Pfg27 is synthesised very early during
gametocytogenesis and peaks in stage II gametocytes (Carter et al., 1989; Lobo et al.,
1994). The transcription of the pfg27 gene is down regulated in the more mature
gametocytes (stages III-V) (Alano et al., 1991; 1996). Another protein known as
Pfsl6, an integral protein of the parasitophorous vacuole membrane, is produced in
sexually committed ring-stage parasites immediately following the invasion of a red
cell by a merozoite. It continues to be produced throughout gametocytogenesis and
in macrogametes (Moelans et al., 1991a;b; Dechering et al., 1997). Pfsl6 is therefore
an excellent marker for sexual differentiation and development in P. falciparum
especially since stage I gametocytes and trophozoites are morphologically
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indistinguishable. In mature stage V gametocytes, Pfs230 and Pfs48/45 are
synthesised and expressed on the surface of mature gametocytes (stage III-V) and
gametes (Williamson et al., 1996; Wizel and Kumar, 1991). Pfs25 is produced only
after induction of gametogenesis within the mosquito midgut and is expressed on the
surface of newly fertilised zygotes and developing ookinetes (Fries et al., 1990).
1.4 Gametogenesis
Gametogenesis is a period of rapid cell division of the mature intraerythrocytic
microgametocyte (male gametocyte) which occurs when it goes from the mammalian
host to the mosquito gut and leads to the formation of several microgametes (male
gametes) (Sinden et al., 1978). Gametogenesis involves the simultaneous activation
of several, apparently independent, cellular events, namely the disruption of the host
cell membrane, release of the parasite, the reorganisation of the cytoplasmic
structures involved in the formation of the male gametes, and lastly the replication of
the genome of the male gametocyte to provide eight gametes. The last two events
comprise the dynamic event classically referred to as exflagellation (Alano and Carter,
1990).
The events of gametogenesis are tightly regulated by environmental changes such as
temperature and pH which are associated with the parasite's transfer to ambient
conditions (Ogwang' et al., 1993; Billker et al., 1997). Factors in the mosquito are
probably essential for gametogenesis during the natural transmission of the parasites.
Induction of gametogenesis, in vitro, requires the simultaneous exposure to at least
two stimuli; a drop in bloodmeal temperature to 5 degrees C below that of the
vertebrate host, and a rise in pH from 7.4 to 8.0-8.2. However, in vivo, the mosquito
bloodmeal has a pH of between 7.5 and 7.6. It is thought that, in vivo, the second
inducer is present within the mosquito midgut that is able to overide the otherwise
suboptimal pH within the mosquito midgut. Recently, xanthurenic acid, a side
product of tryptophan metabolism, has been extracted from the mosquito midgut and
15
implicated as the signal that induces gametogenesis within the mosquito midgut
(Garcia et al., 1998; Billker etal., 1998).
Both temperature and pH are critical in controlling the process of gametogenesis,
though at otherwise permissive conditions of pH (pH 8.0 to 8.2), or in the presence
of pharmacological activators of gametogenesis, gametocytes maintained at normal
host body temperature do not undergo any of the processes of gametogenesis
(Sinden, 1983; Ogwang1 et al., 1993). However, at a few degrees below body
temperature, all three processes may be triggered. Exflagellation, and probably DNA
synthesis, proceed at maximum rate, taking about ten minutes, at the highest
permissive temperature; about 34°C for P. falciparum and about 38°C for P.
gallinaceum (Carter and Graves, 1988).
1.5 Developmentally transcribed ribosomes
One of the remarkable features of Plasmodium parasites is the developmentally
regulated ribosome characterised by transcription in a stage-specific manner of
discrete repertoires of unlinked nuclear rRNA genes, now termed A-type (from
Asexual) and S-type (from Sporozoite) (McCutchan et al., 1995; Waters et al., 1989;
Waters, 1994; Li et al., 1997). A third set of rRNA genes, the O-type, has been
described in P. vivax, where expression is limited solely to developmental stages in
the mosquito (Li et al., 1997). In the human parasite, P. falciparum, the switch from
A- to S-type transcription occurs during gametocytogenesis and zygote formation
and involves accumulation of S-type rRNA precursor forms (Waters et al., 1989).
To date, there has been no mRNA whose translation has been shown to be controlled
by developmentally regulated ribosomes. However, the expression of the P. berghei
21-kDa ookinete surface protein (Pbs21) is regulated translationally in such a way
that it might represent an example of control by developmentally regulated
ribosomes. The mRNA for Pbs21 accumulates in the cytoplasm of female
gametocytes, zygotes, and ookinetes, but the protein is translated only in the
ookinetes (Paton et al., 1993; Vervenne et al., 1994). It is not known why the
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translation of Pbs21 mRNA is repressed prior to the ookinete stage of parasite
development, but it is possible that translation of Pbs21 mRNA is linked to the
synthesis of the S rRNAs which begins in the ookinete (Waters et al., 1997). It has
not been reported yet whether the P. falciparum homologue of Pbs21 (Pfs28) also
undergoes translational regulation.
1.6 DNA replication in eukaryotes
To maintain euploid gene balance, DNA sequences must be replicated in every cell
cycle but not more than once. Recent evidence indicates that cell cycle control of
DNA replication is effected by a two-step mechanism (Diffley 1996). Origins first
become competent to replicate by assembling proteins comprising pre-replication
complexes onto chromatin in Gl, and then later, during S, those origins initiate
replication (Diffley et al. 1994; Bambara et al., 1997). Replication from or through
an origin dissociates functional pre-replication complexes. Once destroyed, these
complexes cannot reassemble until the subsequent Gl, thereby precluding re-firing of
an origin in a single cycle (Wang, 1996; Waga and Stillman, 1998).
Knowledge of DNA replication in eukaryotes comes from extensive studies
performed using cell extracts from mammalian cells that support the complete
replication of plasmid DNA containing the Simian Virus 40 DNA replication origin
(SV40 ori) (Li and Kelly, 1984;85; Stillman and Gluzman, 1985; Wobbe et al., 1985).
Replication of the SV40 DNA, a circular dsDNA virus with a single origin of
replication, requires a single virus-encoded protein, the SV40 large tumour antigen (T
antigen), which functions both as an initiator protein by binding to the SV40 ori and
as a DNA helicase at the replication fork (Figure 1.2). Unwinding of the origin by
large T antigen is stimulated by the ssDNA-binding protein known as replication
protein A (RPA) that binds to single stranded DNA and promotes extensive
unwinding of duplex DNA (Hubscher et al., 1996; Wold, 1997). After unwinding,
DNA polymerase alpha/primase complex (DNAPol alpha/primase) then loads onto
the single stranded DNA and synthesises an RNA primer of approximately 10
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nucleotides (nt) long then extends the primer by polymerisation to produce a short
DNA extension of approximately 30 nt (Bullock et al., 1994). The loading of
DNAPol alpha /primase onto the DNA is called primosome assembly. Once the
RNA-DNA primer is synthesised, a protein known as replication factor C (RFC), a
complex of five subunits, binds to the 3'-end of the initiator DNA (iDNA) displacing
DNAPol alpha/primase in an ATP-dependent process known as polymerase
switching (Hubscher et al., 1996). The binding of RFC to the iDNA triggers the
assembly of the primer recognition complex, which is accomplished through the
loading of another protein known as proliferating cell nuclear antigen (PCNA).
PCNA forms a homotrimeric complex that is topologically linked to DNA by the
RFC thereby allowing PCNA to track along the DNA (Tinker et al., 1994). The
current model suggests that RFC transiently opens the toroid structure of PCNA and
then allows PCNA to re-close, encircling the double helix adjacent to the primer
terminus (Tsurimoto and Stillman, 1990; Burgers and Yoder, 1993). PCNA
subsequently associates with DNA polymerase delta (DNAPol delta) and acts as a
sliding clamp holding the polymerase on the primer terminus. The clamped DNAPol
delta is highly processive, adding thousands Of nucleotides without dissociating
(Waga et al., 1994). For the initiation of leading-strand DNA replication, the DNA
synthesis by the DNAPol delta/PCNA complex is processive and continuous, at
least for 5-10 kb ofDNA. For the lagging-strand, DNA synthesis continues until the
polymerase encounters the previously synthesised Okazaki fragment. A complex
processing reaction then removes the RNA primer from the preceding Okazaki
fragment and the remaining nick is sealed by DNA ligase I (Murante et al., 1998;
Turchi et al., 1994).
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Figure 1.2 Polymerase switching and maturation of Okazaki fragments on a
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1.7 DNA synthesis in Plasmodium
1.7.1 DNA synthesis in asexual parasites
The most extensive studies of DNA synthesis in malaria parasites have been carried
out in rodent malaria parasites, especially P. berghei. These studies have included
analyses of structure (Sinden et al., 1985) and cytology (Canning and Sinden, 1975;
Cornelissen et al., 1984a;b; Janse et al., 1986a;c) and the effects of DNA synthesis
inhibitors (Janse et al., 1986b;c; Toye et al., 1977). During the life cycle of
Plasmodium, DNA replication takes place at five points. The first takes place during
exo-erythrocytic schizogony inside the liver hepatocytes of the vertebrate soon after
sporozoite invasion. The second takes during intra-erythrocytic schizogony in the
vertebrate blood. The third replication of DNA takes place during gametogenesis
within the mosquito midgut and is followed by cytokinesis, fertilisation and
formation of a diploid zygote. The fourth DNA replication takes place in the diploid
zygote prior meiosis and leads to the formation of a haploid ookinete. Finally, the
fifth DNA replication takes place in the oocysts during the formation of sporozoites
(for review, see White and Kilbey, 1996).
1.7.2 DNA synthesis in sexual parasite
1.7.2.1 DNA synthesis during gametocytogenesis
DNA synthesis during sexual differentiation has been studied by the use of direct
microfluorometry of Feulgen-pararosaniline stained parasites. In P. berghei, mature
macrogametocytes and microgametocytes have been shown to have 1.4C and 1.8C
respectively, of the haploid DNA (1C) content (Janse et al., 1986a; Janse et al.,
1986b). In P. falciparum, the DNA content of Stage I gametocytes is about twice
(1.8C) as high as that of haploid (1C) ring-forms implying DNA synthesis during
transformation of the ring-forms into Stage I gametocytes (Janse et al., 1988). In
both cases, the increase in the DNA content at the onset of gametocytogenesis is
probably as a consequence of partial replication or selectively amplification of some
parts of their genome. Synthesis of long-lived mRNAs during gametocytogenesis and
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their translation only during gametogenesis has been strongly suggested following
studies using metabolic inhibitors of nucleic acid synthesis (Toye et al., 1977). It is
therefore possible that these long-lived mRNAs may account, in part, for the
observed increase in the nucleic acid content in stage I and later in stage V
gametocytes. Transcription in P. falciparum occurs in three compartments, the
nucleus, the mitochondrion, and the plastid (Feagin and Drew, 1995; Lanzer et al.,
1992). Actinomycin D, a general inhibitor of RNA synthesis and presumably acting
in all three compartments, effectively inhibits the growth of asexual erythrocytic
stages and early gametocyte stages of P. falciparum, suggesting that RNA synthesis
is essential in these parasite stages (Geary et al., 1989).
1.7.2.2 DNA synthesis during gametogenesis
The synthesis of DNA, RNA and protein is essential for microgametogenesis as
shown by the use of metabolic inhibitors (Toye et al., 1977; Janse et al., 1986b).
Inhibitors of protein synthesis, specifically those affecting peptide elongation, like
emetine, were found to effectively inhibit exflagellation. However, the partial
inhibitory effects of actinomycin D, an inhibitor of DNA-directed RNA synthesis in
both prokaryotes and eukaryotes, brought to light the possibility that transcription
does occur to some extent during microgametogenesis and requires de novo synthesis
of mRNA. Due to this partial inhibitory effect of actinomycin D on exflagellation,
the existence of a long-lived mRNA, presynthesised in the maturing microgametocyte
and translated only at the onset of exflagellation cannot be excluded. Colchicine, an
antimitotic agent that acts by preventing microtubule assembly, was shown to
effectively inhibit exflagellation. This suggests that a protein critical to the assembly
of the mitotic spindle is synthesized or activated at the initiation of gametogenesis.
Studies on DNA synthesis in Plasmodium gametocytes showed that significant
DNA synthesis occurs during gametogenesis (Janse et al., 1986a;b). Aphidicolin, a
proven specific inhibitor of eukaryotic DNA polymerases, was shown to inhibit
gametogenesis in contrast to mitomycin C (Janse et al., 1986b). These results
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indicated that rapid and repeated aphidicolin-sensitive DNA synthesis does occur
during microgametogenesis. Further studies on the cytofluorometric analysis of the
DNA content of P. falciparum gametocytes during gametocytogenesis and
gametogenesis established that micro- and macrogametocytes contain less than twice
the amount of DNA of haploid sporozoites and rings-stages (Janse et al., 1988).
This suggests that DNA synthesis does occur to some extent during the
transformation of ring-forms into stage I gametocytes.
Within 8-10 minutes of induction of microgametogenesis, three endomitotic nuclear
divisions take place. These division are preceded by a very rapid and repeated
replication of the entire parasite genome to 8C (Janse et al., 1986a). It has been
suggested that in order to achieve this rapid and repeated DNA replication,
approximately 1300 replication forks are activated simultaneously in the mature
gametocytes at the onset of microgametogenesis (Janse and Mons, 1987). The
induction of so many independent replication forks at the onset of
microgametogenesis itself not only suggests that mature microgametocytes are
heavily precommitted to the rapid production of male gametes in the mosquito
midgut but also that the induction mechanism is highly amplified within the parasite
nucleus.
1.8 Genes involved in P. falciparum DNA replication
Several genes that code for proteins involved in DNA replication machinery in P.
falciparum have been cloned and characterised. Most of these genes were identified
by screening genomic and cDNA libraries with either oligonucleotides designed to
conserved regions or heterologous screening with Saccharomyces cerevisiae gene
fragments.
1.8.1 Replication factor C (RFC)
RFC is a complex of five-subunits of high sequence similarity that bind to the
primer-template junction and load PCNA onto the DNA in the presence of ATP
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(Cullman et al., 1995). All five subunits have been identified in both humans and
yeast. In yeast, the five subunits are referred to as RFC1, RFC2, RFC3, RFC4 and
RFC5 whereas in humans, these subunits are referred to as pi40, p37, p36, p40 and
p38. In both the yeast and humans, the proposed function of individual subunits
within the RFC complex is similar but not identical (Table 1.1).
The genes encoding PfRFCl, PfRFC2 and PfRFC3 have been isolated and
characterised (Jill Douglas, Ph.D thesis, 1999). PfRFCl is a single copy gene on
chromosome 2, has open reading frame is 2712bp, which predicts a protein of 904
amino acids with a molecular weight of 104kDa. There are no introns present in this
gene. Northern analysis detected a transcript of 4kb in size, present predominantly
in trophozoites. PfRFC2 is also a single copy gene on chromosome 2. It is
transcribed in the opposite direction to and approximately 40kb apart from PfRFCl.
PfRFC2 has an open reading frame of 990bp, which predicts a protein of 330 amino
acid residues with a molecular weight of approximately 38kDa. There are no introns
present in this gene. Northern analysis detected a transcript of 1.6kb in size, present
in trophozoites and two larger transcripts of 2.5 and 4kb in schizonts. The third
subunit, PfRFC3, is a single copy gene on chromosome 14. PfRFC3 has an open
reading frame of 1032bp, which predicts a protein of 344 amino acid residues with a
molecular weight of approximately 39kDa. There is one intron of 250bp present at
the 5' end of the gene. PfRFC3 has two transcripts of 1.4 and 1.8kb present in
trophozoites and schizonts. All the three proteins, PfRfcl, PfRfc2 and PfRfc3
accumulate in the trophzoite stage of the asexual parasites. Immunofluorescence
assays showed that all three PfRfc proteins localised to nucleus of both trophozoites
and schizonts.
The genes encoding PfRFC4 and PfRFC5 have been identified and their
characterisation is in progress (Spielmann and Beck, 2000). P. falciparum RPA
(PfRPA) has been identified and is at present being characterised (Kilbey B, personal
communication).
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1.8.2 Proliferating cell nuclear antigen (PCNA)
PCNA was identified as a protein that accumulated during the S-phase of the cell
cycle (Bravo and Cellis, 1980; Bravo, 1986) and was therefore thought to be a cyclin.
PCNA was later shown to associate with DNAPol delta and acts as a sliding clamp
holding the polymerase on the primer terminus. PCNA is a protein with an apparent
molecular weight of 36kDa. PCNA forms a homotrimeric complex that is
topologically linked to DNA by the RFC thereby allowing PCNA to track along the
DNA (Tinker et al., 1994).
PfPCNA has been cloned (Kilbey et al., 1993) and was found to be located on
chromosome 13 as a single copy with no introns. The gene is 825bp long and
encodes a polypeptide of 275 amino acid residues with a predicted molecular weight
of approximately 30.5kDa. Two transcripts were detected; a major one of 1.6kb and
a minor one of 2.2kb. PfPCNA protein and transcript accumulate in trophozoites
and persist through to schizonts. However, nuclear run-on analysis showed that
PfPCNA promoter activity was present throughout the intraerythrocytic asexual
cycle. This led Horrocks et al., (1996) to suggest a post-transcriptional regulation of
PfPCNA.
1.8.3 DNA polymerases
1.8.3.1 DNA polymerase alpha (Pol alpha)
DNA polymerase alpha is responsible for initiating DNA replication on both the
leading and the lagging strands. The enzyme consists of a subunit containing
polymerase activity (205kDa), two subunits with primase activity (55-60kDA and
48-5OkDa) and a 70kDa subunit with unknown function (Wang, 1991).
PfDNA POL a has been isolated and characterised (White et al., 1993) and encodes
for a protein of a predicted molecular weight of 205kDa. The gene is present as a
single copy on chromosome 4 and has a length of 5.7kb with a single intron of 204bp.
A transcript of 7kb has been detected with an open reading frame of 1855 amino acid
residues. Examination of the polypeptide sequence revealed the presence of seven
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sequence motifs that characterise eukaryotic DNA polymerases. Of the five motifs
specific for DNA polymerase a, four have been identified in PfDNA Pola. One of
the two primase subunits with primase activity has also been isolated from P.
falciparum (Prasartkaew et al., 1996). The gene has an open reading frame of 1356bp
encoding a protein of 452 amino acids with a molecular weight of 53kDa. The gene
was found to contain 15 introns and a single transcript of 2.1kbp. The coding
sequence was expressed in baculovirus and the purified recombinant primase protein
was able to initiate de novo primer formation.
1.8.3.2 DNA polymerase delta
DNA polymerase delta is required for the elongation of both the leading and lagging
strands of DNA (Tsurimoto and Stillman, 1990). The enzyme consists of two
subunits; a catalytic subunit of 125kDa with both polymerase and 3'-5' exonuclease
activity and a second subunit of 50kDa with an unknown function (Syuaoja et al.,
1990).
PfDNA POLS has been cloned (Fox and Bzik, 1991; Ridely et al., 1991). The gene
exists as a single copy on chromosome 10 and contains no introns. A transcript of
5.2kb encodes a polypeptide of 1094 amino acid residues with a predicted molecular
weight of 120kDa. The amino acid sequence of PfDNA PolS contains all seven
motifs used to identify DNA polymerases. PfDNA PolS protein and transcript
accumulate in trophozoites and persist through to schizonts. However, nuclear run-
on analyses showed that PfDNA PolS promoter activity was absent in rings but
present in trophozoites. This was thought to suggest pre-transcriptional regulation
ofPfDNA PolS (Horrocks et al., 1996).
1.8.4 Topoisomerases
DNA topoisomerases alter the topological state of DNA by catalysing the breaking
and rejoining ofDNA strands. DNA topoisomerases are therefore essential for DNA
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replication, transcription, recombination and chromosome structure. They are
classified as type-I enzymes if they cleave a single strand of the DNA duplex and as
type-II if they cleave both strands (Wang, J. C, 1996).
1.8.4.1 Topoisomerase I (Topol)
Prokaryotic and eukaryotic topoisomerase type-I enzymes are active as monomers
and their biological function of topoisomerase I has been studied extensively (Gupta
et al., 1995). Studies in cell-free SV40 DNA replication system have shown that free
topoisomerase I binds to a specific site on double strand DNA, causes a transient
single-strand DNA break and becomes covalently linked to the 3'-phosphoryl end of
the nicked DNA. The intact strand passes through the nick; DNA relaxation results
from swivelling at this nick. Topoisomerase I then reseals the cleaved strand and
dissociates from the DNA (Dean and Cozzarelli, 1985). Topoisomerase I probably
functions as a swivel to release the local supercoils generated during transcription
elongation. Increase in levels of topoisomerase I in some tumours especially those of
epithelial origin, as compared with normal tissues, suggest that this enzyme can be a
target for anti-cancer agents (Liu, 1989).
PfTOPO I has been isolated (Tosh and Kilbey 1995) and was found to be located on
chromosome 5 as a single copy with no introns. The gene has an open reading frame
of 2520bp that encodes a polypeptide of 839 amino acid residues with a predicted
molecular weight of 116kDa. A single transcript of 3.8kb was identified by northern
analysis. PfTOPO I transcript levels are highest in trophoziotes and decrease in
schizonts. Nuclear-run-on assays indicated that the promoter is only active in
trophoziotes and schizonts and not in early ring-stages. PfTopoI protein was shown
to present at low levels in rings, but accumulating to equal levels in trophozoites and
schizonts. Topol activity assays showed schizonts had the highest level of PfTopoI
activity (Tosh et al., 1999).
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1.8.4.2 Topoisomerase II (TopoII)
The eukaryotic type-II topoisomerase is active as two identical subunits forming a
homodimer, each subunit acting on complementary DNA strands. Type-II
topoisomerases catalyse the formation of transient double-stranded breaks in a DNA
duplex and each duplex becomes covalently linked to each subunit of the enzyme via
the 5'-phosphoryl end. The second intact DNA duplex is then passed through the
double-stranded DNA gate, type-II topoisomerase reseals the gap and dissociates
from the duplex DNA. Type-II DNA topoisomerases, unlike type-I, appear not
play a direct role during early DNA replication (transcription) but are needed for the
resolution of late replication intermediates (Ishimi et al., 1992; Clarke et al., 1993).
PfTOPOII has been isolated and characterised (Cheesman et al., 1994). It has an
open reading frame of 4194bp and is located on chromosome 14 as a single copy and
contains no introns. Three transcripts of approximately 6, 7 and 8kb are seen in
trophozoites but only the major 6kb transcript is seen in the ring-forms. The major
6kb transcript encodes a polypeptide of 1398 amino acid residues with an
approximate molecular weight of 160-175kDa. PfTOPOII shares a 65% sequence
similarity with the human TOPOII alpha isoform (Cheesman et al., 1994).
PfTopoII is present in both trophozoites and schizonts as a triplet of proteins and at
similar levels and localises to the nucleus. The PfTopoII transcripts accumulate
principally in the trophozoites but are not detectable in the schizonts. However,
nuclear-run-on analysis showed that the PfTOPOII promoter remained active
throughout the asexual cycle. Topoisomerase II activity was found to be higher in
schizonts than in trophozoites with no activity present in the ring-forms (Cheesman
et al., 1998).
27
1.9 Rationale and scope of thesis
DNA synthesis in gametocytes takes place at two points; at the onset of
gametocytogenesis where the nucleic acid content increases from lc to 1.8c prior to
the formation of stage I gametocytes, and again 10 to 12 days later at the onset of
gametogenesis when the mature male gametocyte (stage V) replicates its genome three
times leading to the formation of eight haploid male gametes in less than 10 minutes.
Naturally, questions then do arise as to the status of the parasite's DNA replication
apparatus during most of gametocytogenesis; from stage I through to stage V
gametocytes. What happens to the components of the parasite's DNA replication
apparatus after the initial DNA synthesis at the onset of gametocytogenesis; are they
broken down or do they still remain present and active throughout
gametocytogenesis? What happens upon activation of mature gametocytes? Are
new components of the DNA replication apparatus synthesised or are pre-existing
proteins activated?
The primary objective of this study was to answer some of these questions. The
proteins investigated in this study were, replication factor C, proliferating cell nuclear
antigen and topoisomerase II. The P. falciparum homologues of these proteins,
PfRfcl, PfRfc2, PfRfc3, PfPcna and PfTopoII, had already been identified in Prof.
Kilbey's lab, expressed as recombinant proteins and rabbit antisera against all of
them was available. The detection of these proteins in situ during gametocytogenesis
by the use of indirect immunofluorescence assays and Western blot analysis during
gametogenesis will be described. Gametocyte RNA will also be analysed by RT-
PCR for the presence of transcripts of these genes before and after activation. An
attempt to carry out RNA in situ hybridisation on asexual parasites using probes
specific for genes involved in P. falciparum DNA replication will also be described.
At present, three components of the DNA replication apparatus, Primase, PfTopoI
and PfTopoII, can be reliably assayed for activity. The activity of PfTopoII in







Unless specified otherwise, Sigma Chemical Co. Ltd, UK, supplied all chemicals
used. Cell culture reagents were supplied by Gibco Life Sciences, UK. FSA
Laboratory Supplies, UK, supplied solvents.
2.1.2 Equipment
Bench top centrifugation was carried out using a Heraeus Biofuge 13 (Eppendorf,
Germany) or a Jouan CR322 (Saint-Herbian, France).
PCR was carried out using a Techne PCR machine from Techne Instruments, UK.
Beckton Dickinson Labware, UK, supplied the plasticware.
RNA hybridisations were carried out in Techne Hybridiser HB-1 oven from Techne
Instruments, UK.
In situ hybridisations were carried out on a Biometra UNO-Thermoblock™ from
Biometra, UK.
Fluorescence was observed using a Leitz fluorescence microscope and images
captured using a Hamamatsu digital camera C4742-95.
2.1.3 Bacterial strains
Bacterial strains used were TOP 10 (Invitrogen)and XL 1-Blue (S) (New England
Biolabs). Genotypes were:
TOP 10;
F'mcrA A(mrr-hsdRMS-mcrBC) ASOlacZ AM 15 AlacXIA recAX deoR araD 139
A{ara-leu)1691 galXJ galK rpsL (StrR) endA1 nupG.
XL 1-Blue (S);




Invitrogen, UK, supplied the pCR®2.1 (3.9kb) plasmid used in cloning of PCR
products. Roche Diagnostics and Biochemicals, Germany supplied pST18 plasmid
used in the in vitro transcription (DIG RNA labelling) experiments.
2.1.5 Parasites
In this study, Plasmodium falciparum clone 3D7A strain was used exclusively to
grow gametocytes in vitro. P. falciparum 3D7A is a clone of isolate NF54. NF54
was isolated from a naive patient living near Schipol Airport, Amsterdam, and was
propagated in vitro and distributed to laboratories all over the world. It is mainly
used by researchers interested in the study of P. falciparum gametocytes as it easily
forms gametocytes in larger quantities than other isolates (Teklehaimanot, et al.,
1987).
2.1.6 Human red blood cells and plasma/serum
Fresh whole human blood of blood group O Rhesus + was obtained from the
Edinburgh and Southeast Scotland Blood Transfusion Services.
2.1.7 DNA size markers
New England Biolabs supplied 100 base pair (bp) and 1 kilo base pair (kbp) DNA
markers that were used. The lOObp markers produced DNA fragments of 100, 200,
300, 400, 500/517, 600, 700, 800, 900, 1000, 1,250, l,500bp. The lkbp markers
produced DNA fragments of 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 5.0, 6.0, 8.0 and lO.Okbp.
0.5pg ofDNA molecular weight marker in IX DNA loading buffer was run per lane.
2.1.8 Imaging
Following electrophoresis, nucleic acids on ethedium bromide gel visualised by
placing gel on an UV-transillunminator and a photographed taken using a Mitsubishi
Video processor to heat sensitive film.
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2.2 Buffers and media
Luria-Bertani medium (LB)
1% bacto-tryptone; 0.5% Bacto-yeast extract; 1% sodium chloride adjusted to pH
7.2, using 1M sodium hydroxide. LB was supplied by ICMB media services.
LB agar
LB supplemented with 1.5% agar. LB agar was supplied by ICMB media services.
MOPS SDS Running Buffer (20X)
1M MOPS; 1M Tris Base; 69.3mM SDS; 20.5mM EDTA.
NuPage Transfer Buffer 120X1
500mM Bicine; 500mM Bis-Tris; 20.5mM EDTA; ImM Chlorobutanol.
NuPage Sample Buffer (4X)
4.00g Glycerol; 0.682g Tris Base; 0.666g Tris-HCl; 0.006g EDTA; 0.75ml of a 1%
(w/v) Serva Blue G250 and 0.25ml of a 1% (w/v) Phenol red solution. Total volume
of 10ml. Novex Electrophoresis GmbH, Germany supplied constituted buffer.
RNA Sample buffer
250jul Formamide (deionised), 83pil of 37% (v/v) Formaldehyde, and 50pil of 10X
MOPS buffer.
RNA Loading buffer (5X)
50% (v/v) Glycerol, ImM Na2EDTA, and 0.4% Bromophenol blue.
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RNA pre-hvbrisation solution
50% (v/v) formamide, 5X SSC, 1% (w/v) blocking reagent, 0.02% (v/v) SDS and
0.1% (w/v) lauryolsarcosine.
RNA Blocking reagent (10% (w/v))
10% (w/v) blocking reagent dissolved in Maleic acid buffer pH 7.5, autoclaved
Maleic acid buffer pH 7.5
0.1 mM Maleic acid, 0.15M NaCl; pH 7.5 (+20°C); adjusted with solid or
concentrated NaOH and autocalved.
RNA Washing buffer
lOOmM Maleic acid, 150mM NaCl; pH 7.5; 3% (v/v) Tween® 20
RNA-DIG Detection buffer
0.1M Tris-HCl, pH 9.5; 0.1M NaCl
Nitro blue tetrazolium fNBT) formulation (Promega. UK)
50mg NBT in 70% formamide
5-bromo-4-chloro-3-indolyl-phosphate (BCIP) formulation (Promega. UK)
50mg/ml in 100% dimethylformamide
Tris-Buffered Saline with Tween® 20 (TBST)
50mM Tris-HCl (pH 7.5), 150mM NaCl and 0.1% (v/v) Tween 20
Alkaline Phosphatase Buffer (APB)
lOOmM Tris-HCl, pH 9.5; lOOmM NaCl, and 5mM MgCl2.
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DNA loading buffer C5X)
25% (v/v) Glycerol; 5% Sarkosyl; 0.0025% Bromophenol blue.
Parasite lysis solution
50mM Tris-HCl; 150 mM NaCl; 5 mM EDTA; 0.5% Triton X-100; 0.01% sodium
azide in distilled water. The following protease inhibitors were added: 5mM
iodoacetamide, lOpg/ml Soybean trypsin inhibitor; 1 pg/ml aprotonin; 10 pg/ml
Tosyl-L-phenylalanine chloromethyl ketone (TPCK), 75 pg/ml
Phenylmethylsulphonyl fluoride (PMSF) and the pH adjusted to 7.4.
Parsite culture medium
Incomplete culture medium fICM)
25mMHEPES; 50pg/ml of hypoxanthine; 50pg/ml gentamycin; 25 mM NaHC03 in
RPMI 1640. The medium was filtered through a 0.22pm Nalgene filter and stored at
4°C for up to 4 weeks.
Complete culture medium (CCMA1
25mM HEPES; 50pg/ml of hypoxanthine; 50pg/ml gentamycin; 25mM NaHC03;
lOg/L AlbuMaxII in RPMI 1640. The medium was filtered through a 0.22pm
Nalgene filter and stored at 4°C for up to 4 weeks.
Complete culture medium fCCMSl
To a suitable amount of ICM, heat-inactivated human serum was added to make 10%
(v/v) heat-inactivated human serum in ICM. It was filtered through a 0.22 pm
Nalgene filter and stored at 4°C for up to 4 weeks.
Gametogenesis stimulating medium
0.5pM xanthurenic acid in RPMI medium, set to pH 7.4 using NaOH.
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2.3 Parasite culture
2.3.1 Preparation of red blood cell
The blood was centrifuged at 1,500 g for 10 minutes at 4°C. The plasma was
carefully aspirated and kept at -20°C while the "buffy coat" of white blood cells at
the top of the cell pellet was aspirated and discarded. The red cell pellet was washed
two times with 2 volumes of ICM and the resulting suspension centrifuged at l,500g
for 5 minutes at 4°C. After the last wash, the red blood cell pellet was re-suspended
in one volume of ICM to make a 50% red blood cell suspension (50% haematocrit)
which was kept at 4°C and used within two weeks.
2.3.2 Preparation of human plasma
Plasma isolated from whole human blood collected each week from the Edinburgh and
Southeast Scotland Blood Transfusion Services was pooled and carefully dispensed
into sterile 50ml centrifuge tubes, and heat-inactivated in a water bath at 56°C for 40
minutes. The heat-inactivated plasma was then centrifuged at 1,500 g (3,000 rpm)
for 10 minutes at 4°C. Plasma was removed and stored at -20°C.
2.3.3 Establishment and maintenance of asexual blood cultures
Plasmodium falciparum strain 3D7A was cultured in vitro using the method of
Trager and Jensen (1976) as modified by Ifediba and Vandeberg (1981). The culture
procedures and related activities were carried out under aseptic conditions. A vial of
P. falciparum strain 3D7A was removed from liquid nitrogen storage and allowed to
thaw quickly at 37°C. The content was transferred to a 15ml centrifuge tube and
centrifuged at l,500g for 10 minutes at room temperature. The supernatant was
discarded and 0.3ml of 3.5% (w/v) NaCl added and the suspension centrifuged at
l,500g for 10 minutes at room temperature. The supernatant was discarded again
and 1ml of complete culture medium (CCMA) (section 2.2) added and the
suspension re-centrifuged at l,500g for 10 minutes at room temperature. The
35
supernatant was discarded and the cell pellet size was visually estimated. The
appropriate amount of 50% washed human erythrocytes were added to make a
packed cell volume of 0.3ml to which 4.5ml of CCM were added to make a 5ml
culture at 6% haematocrit. This suspension was transferred into a 25cm2-base
canted-neck culture flask, aerated with culture gas mixture (92% N2, 5% 02, and 3%
C02) and maintained in an incubator at 37°C. Spent medium of the culture was
removed every 24 hours by tilting the flask towards the front and aspirating the
medium and replacing with 4.5ml of fresh pre-warmed complete medium. The
parasitemia of the culture was monitored daily by observing Giemsa-stained thin
films (section 2.3.9 and 2.3.10) of the culture on an Olympus BH-2 Microscope at
XI,000 magnification (oil immersion). When the parasitemia reached 5-6%, the
culture was diluted by adding fresh RBCs to reduce the parasitemia to around 1%.
2.3.4 Growth of blood cultures for gametocyte production
The method used was as described by Carter et al., (1993). The parasitized RBCs
from an asexual culture at a parasitemia above 4% were diluted with fresh RBCs to
give a starting parasitemia of 0.5%. The diluted culture was dispensed in 5ml
volumes at 6% haematocrit in 25cm2-base, canted-neck, cell culture flasks and the
flasks aerated with culture gas mixture and maintained in an incubator at 37°C.
Medium was replaced in each culture flask every 24 hours with 4.5ml of pre-warmed
complete medium. About 2-3 days after the dilution of the cultures, thin films of all
the parasites cultures were made and stained with Giemsa (section ). Parasites were
examined microscopically for morphological changes associated with stress, such as
slightly triangular ring-forms. When these signs appeared, the haematocrit was
reduced to 3.6% by increasing the volume of complete medium from 5ml to 8.5ml per
flask. At the first sign of the presence of stage I gametocytes (usually 72 hours after
lowering the culture haematocrit), the gametocyte cultures were maintained in
CCMA containing 50mM N-Acetyl glucosamine (GluNAc) for 72 hours with
medium changes every 12 hours (Ponnudurai et al., 1986). Thereafter, the gametocyte
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cultures were maintained with 24 hourly medium changes in standard CCMA until
mature stage V gametocytes (Hawking et al., 1971) were present, typically 14 to 16
days after the last dilution of the cultures.
Mature gametocytes undergo gametogenesis at temperatures below 30°C. They can
also be triggered to exflagellate by suspension in a bicarbonate ion-containing buffer
at pH 8.0 (Ogwang' et al, 1993). In order to minimize the risk of activating the
gametocytes, all efforts were made to keep the gametocytes at 37°C prior to the
induction of suspended animation in bicarbonate-free medium (ICM).
2.3.5 Testing for activation/exflagellation
Fifty microlitres of a 16 day-old gametocyte culture were placed in a sterile
microfuge tube and micro-centrifuged for 4 seconds at room temperature. The
supernatant was discarded and cell pellet was re-suspended in 50pl of Gametogenesis
stimulating medium (GSM). 20pl of this suspension was placed on a
haemocytometer and examined under a phase contrast microscope (x400
magnification). The gametocyte cultures were taken to reached full morphological
and physiological maturity when at least 20 percent of the gametocytes exflagellated,
that is, at least two centres of movement (COM) per ten gametocytes. A COM
represented an exflagellating body with several microgametes.
2.3.6 Preparation of purified mature gametocytes of P. falciparum using
Percoll
This was done according to the method initially described by Knight and Sinden
(1982) and modified by Kariuki et al (1998). Percoll (1.130 g/ml) was made isotonic
by adding 1 volume of 10X ICM to 9 volumes of stock Percoll to make a 90%
Percoll isotonic solution. This solution was then diluted to 80%, 65%, 50%, and
35% with ICM and allowed to equilibrate to room temperature prior to use. A
discontinuous gradient was prepared carefully by successively layering 1.5ml of each
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Percoll dilution in a tilted 15ml centrifuge tube, starting with the highest Percoll
concentration.
Spent medium was removed from a mature gametocyte culture (16 day-old) and pre-
warmed (37°C) ICM added immediately. The gametocyte culture suspension was
transferred into a 15ml centrifuge tube and centrifuged at l,500g for 5 minutes at
37°C. The supernatant was discarded and the infected erythrocyte pellets washed
twice, by centrifugation (l,500g for 5 minutes at 37°C), with warm ICM and re-
suspended again in ICM to make a 20-30% haematocrit in a maximum volume of
1.5ml. The infected erythrocyte suspension was carefully layered over the prepared
discontinuous Percoll gradient and centrifuged at l,750g for 10 minutes at room
temperature with the brakes off. The resultant band of parasites at the 35/50%
Percoll interphase (Percoll Fraction 2) was carefully removed using a Pasteur pipette
and washed twice in 10 volumes ICM to remove any traces of Percoll. The parasite
pellet, now comprising mainly of gametocytes, was used immediately for
gametogenesis (section 2.3.7) or stored as dry pellet at -70°C until required.
2.3.7 Timing of Gametogenesis
This experiment was carried out using the purified gametocytes isolated from the
35/50% Percoll interphase (Percoll Fraction 2 (F2)). A purified F2 gametocyte pellet
was re-suspended in 400(il of ICM. lOOpl were removed and transferred into a
sterile microfuge tube and micro-centrifuged for 4 seconds at 4°C. The supernatant
was carefully removed and discarded. The dry pellet was labeled as Mature
Inactivated Gametocytes (MIG) and immediately stored at -70°C. The remaining
300pl parasite suspension was micro-centrifuged for 4 seconds at 4°C and the
supernatant carefully removed and discarded. The pellet was then re-suspended in
300pl of Gametogenesis stimulating medium (GSM). lOOpl aliquots of this
suspension were withdrawn at five minutes intervals. On each occasion, the aliquot
was transferred into sterile 1.5ml microfuge tube and then rapidly micro-centrifuged
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for 4 seconds at 4°C. The supernatant carefully removed and discarded. The cell
pellet was washed once with chilled ICM, labeled appropriately, and the dry pellet
immediately stored at -70°C. These pellets were labeled as Mature Activated
Gametocytes at 5, 10 and 15 minutes after activation (MAG 5, MAG 10, and MAG
15). These parasite pellet-sets were used to prepare lysates for the Western blot
analysis, Topoisomerase II activity assays and northern analysis.
2.3.8 Saponin lysis of infected erythrocytes
Infected erythrocytes from in vitro cultivated P. falciparum 3D7A cultures were
collected by centrifugation at 2000g for 10 minutes at 4°C and the supernatant
discarded. The infected erythrocyte cell pellet was re-suspended in 5 volumes of
0.1% (w/v) saponin and incubated for 5 minutes at room temperature. The released
parasites were collected by centrifugation at 2000g at 4°C for 10 minutes. The
supernatant was discarded and the parasite pellet washed twice in 5 volumes of ice-
cold ICM. The dry parasite pellet was stored at -70°C until required.
2.3.9 Preparation of parasite films on microscope glass slides
Parasite films were prepared as described by Dacie and Lewis (1991) and Weindy
(1991). A small drop of parasitized erythrocytes from a culture flask or those
obtained after Percoll step gradient centrifugation was placed in the centre line of a
clean microscope glass slide about 1 or 2cm from one end. Then, without delay, a
second glass slide (spreader) with a smooth edge was placed width-wise at an angle
of 45° to the slide and moved back to make contact with the drop of parasitized
erythrocytes. After the drop spread out along the line of contact of the spreader and
the glass slide, making a rapid, smooth and forward movement of the spreader made a
thin film. The thin film was air dried for 10 minutes at room temperature.
To prepare a thick film, a small drop of parasitised erythrocytes was placed at the
centre of a glass slide and spread out with the corner of another slide using circular
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motions to cover an area about four times its original area. The thick film was dried
as described above.
2.3.10 Giemsa staining of parasite films
Parasite films were stained according to the method described by Dacie and Lewis
(1991) and Wendy (1991). Once dry, the thin film was fixed by placing the slide in
100% methanol for 10 seconds at room temperature. The slide was removed and
allowed to drain off and dry at room temperature after which it was placed for 10
min at room temperature in a trough containing Giemsa's stain (BDH) freshly diluted
to 10% (v/v) with phosphate buffered water (pH 6.8). The excess stain was washed
off with tap water and the films allowed dry in an upright position at room
temperature.
The same staining procedure described above was used for thick parasite films,
however, thick films were not fixed but were stained immediately after they had
dried.
2.3.11 Sorbitol treatment of parasite cultures
Mature asexual parasites, trophozoite and schizonts, were eliminated by the sorbitol
treament of culture according to the method described by Lambros and Vandenberg
(1979). The culture was centrifuged (2000xg, lOminutes, 4°C) and the infected
erythrocyte pellet resuspended in 5 volumes of sterile 5% sorbitol. The culture was
incubated at room temperature for 5 minutes and the culture collected by
centrifugation (2000xg, 10 minutes, 4°C). The infected erythrocyte pellet was
washed in 5 volumes of in ICM (2.2), collected by centrifugation (2000xg, 10
minutes, 4°C) and resuspended in CCMA at 6% haematocrit. The culture was
gassed then incubated at 37°C. The culture was examined after 48 hours, and if
necessary, the protocol was repeated to ensure tight synchrony.
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2.4 Protein methods
2.4.1 Isolation of total parasite protein
Parasites released from infected erythrocytes by saponin lysis (section 2.3.8) were
re-suspended in 5 volumes of parasite lysis solution (see section 2.2). The lysate
was passed repeatedly through a G25 hypodermic needle to aid complete lysis and
reduce viscosity of the sample. Lysate was cleared of debris by micro-centrifuging at
13,500rpm for 10 minutes at 4°C. Cleared lysate was transferred to a sterile
microfuge tube and stored at -70°C until required.
2.4.2 SDS-Polyacrylamide gel electrophoresis (PAGE)
2.4.2.1 Preparation of sample solution for electrophoresis
Typically, a total of 10pl of sample solution was made up. To 5|il of total parasite
lysate (containing approximately lpg of total protein) was added 2.5ptl of 4X SDS
Sample Buffer, 1.5pl of sterile distilled water and lOpl of reducing agent (0.5M
DTT). The sample solution was mixed gently heated at 70°C for 10 minutes,
vortexed to mix and used for electrophoresis. 10pl of pre-stained broad range protein
molecular weight markers (New England Biolabs) were also heated to 70°C for 10
minutes, vortexed to mix and used for electrophoresis.
2.4.2.2 NuPAGE gel for electrophoresis
The NOVEX™NuPAGE Bis-Tris Electrophoresis System was used. NuPAGE Bis-
Tris System is a revolutionary neutral pH, pre-cast polyacrylamide mini-gel system.
10% acrylamide pre-cast gels were used. Combs were gently removed from the pre¬
cast gel and the wells rinsed with sterile distilled water. The gels were assembled in
the Mini-Cell following the manufacturer's instructions. 1000ml of a IX NuPAGE
MOPS running buffer was prepared and 200ml set aside. 500pl of NuPAGE
Running Buffer Antioxidant was added 200ml of running buffer, mixed by inversion
and poured into the upper buffer chamber of the Mini-Cell. Samples were loaded
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onto the gel and the lower (outer) chamber filled with about 600ml of the remaining
800ml of IX running buffer. The gels were electrophoresed at a constant voltage of
200V for 55 minutes at room temperature.
Coomassie-staining of gels in order to visualise protein profiles was carried out by
incubating the gel in 5 volumes of 0.05% Coomassie brilliant blue R-250 in water for
10 minutes. The gel was then rinsed in distilled water and visualised over a light box.
2.4.2.3 Western blot transfer
Nitrocellulose paper was cut to the exact size of the gel and immersed for several
minutes in IX NuPAGE transfer buffer comprising of 10% methanol and 0.1%
NuPAGE Sample Antioxidant. Gel was released from the plastic cassettes and
placed on a pre-wet nitrocellulose paper (Hybond C, Amersham) and sandwiched
between 2 sheets of blotting paper and blotting pads. The gel membrane sandwich
was assembled in the Blot Module, with the gel closest to the cathode, and covered
with IX transfer buffer. The outer chamber was filled with sterile distilled water to
about 2cm from the top. The gel was transferred at 30 Volts for 1 hour at room
temperature.
2.4.2.4 Probing of Western blots
After transfer, the protein molecular weight markers were cut out and kept while the
rest of the blot was blocked with blocking buffer (TBST containing 5% (w/v) non-fat
milk powder) for 1 hour, at room temperature, with gentle agitation. The
appropriate dilution of rabbit antiserum in blocking buffer was added to the blot
which was then incubated for a further 2 hours at room temperature with gentle
agitation. The blot was washed twice, 10 minutes for each wash, in TBST followed
by incubation in a 1:7500 dilution of goat anti-rabbit IgG-AP in blocking buffer for 1
hour at room temperature. The blot was washed twice, 10 minutes for each wash, in
TBST at room temperature.
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2.4.2.5 Detection of Western blots
Following the washes in TBST, the membrane was incubated in APB for 5 minutes
at room temperature. The blot was then incubated in 10ml of APB containing 66|il
ofNBT (50mg/ml) and 33|il of BCIP (50mg/ml) until a coloured precipitate formed.
The blot was washed in distilled water to prevent over-development, air dried and
stored in the dark.
2.4.3 Immunofluorescence microscopy
Standard double IFA was performed using rabbit pre-immune and immune
(antiserum) serum produced against recombinant proteins ofwhole or part of PfRfcl,
PfRfc2, PfRfc3, PfPcna and PfTopoII. A mixture ofmouse anti-Pfs230 (12F10) and
anti-Pfg (1H12) 27/25 monoclonal antibodies which specifically recognise
gametocytes were included in the assays in order to help distinguish between asexual
and sexual parasites. These monoclonal antibodies were kindly donated by Prof.
Richard Carter, Institute of Cell Animal and Population Biology (ICAPB),
University of Edinburgh.
A thin blood film of infected erythrocytes from unsynchronised cultures containing
both asexual and sexual stages of P. falciparum at 5% parasitemia were prepared on
glass microscope slides. The films were air-dried and fixed in acetone for 5 minutes
at room temperature. A grid was drawn on the slide with nail varnish. Onto each
section of the grid, 40|li1 of the primary antibody solution was added and the slide
incubated in a moist chamber for 1 hour at room temperature. The primary antibody
solution comprised of a 1:80 dilution of appropriate rabbit immune antiserum or pre-
immune serum, 1:1,000 dilution of mouse anti-Pfg 27/25 monoclonal antibody
(1H12) and a 1:2,500 dilution ofmouse anti-Pfs 230 monoclonal antibody (12F10) in
blocking buffer (PBS containing 1% (w/v) BSA). The slide was washed twice, 15
minutes each, in PBS at room temperature and incubated in a moist chamber for 1
hour at room temperature in secondary antibody solution. The secondary antibody
solution comprised of a 1:80 dilution of Goat anti-rabbit TRITC (Sigma) conjugated
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antibody and a 1:50 dilution of Goat anti-mouse FITC in blocking buffer. The slide
was washed twice, 15 minutes each, in PBS at room temperature and then incubated
in PBS containing 0.5pg/ml DAPI for 5 minutes at room temperature and followed
with a quick rinse in sterile distilled water. The slide was mounted in Mowiol
mounting medium and examined by fluorescence microscopy and images captured on
a digital camera.
Trophozoites in the mixed cultures were used as internal positive controls. Mouse
anti-Pf 27/25 and anti-Pfs 230 monoclonal antibodies, are gametocyte-specific
antibodies, and were included in the primary antibody solution in order to help
distinguish between asexual and sexual stages of the parasite.
2.4.4 Affinity purification of rabbit polyclonal antiserum
Western blot analysis, using unsynchronised parasite extract and a rabbit antiserum
derived against P. falciparum DNA replication proteins, was carried out essentially
as described in (2.4.2) but with a few alterations. Parasite extract was loaded in a
central trough and pre-stained protein molecular weight markers loaded on both the
peripheral wells and the protocol followed as described. Following the washing
steps after the incubation with rabbit antiserum, only thin strips cut off from the
peripheral ends of the blot were probed with AP-conjugated antibody and bound
conjugate detected as described in section 2.4.2.4. Meanwhile, the remaining central
part of the blot was left in washing buffer. Following detection, the peripheral strips
were aligned with the central blot and a strip of the central blot, at the position
corresponding to the prominent bands seen on the peripheral strips, was cut out and
incubated in a microfuge containing lOOmM glycine (pH 2.5) for 10 minutes at room
temperature. Following a brief spin, the supernatent was transferred to a fresh
microfuge tube and the pH neutralised by the addition of a tenth volume 1M Tris-
HC1 (pH 8.0). The affinity purified polyclonal antibody solution was stored at
-20°C until required.
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2.4.5 Topoisomerase II decatenation assays
TopoGEN, USA supplied the Topoisomerase II assay kit. Percoll purified
gametocytes (F2) pellets (2.3.6), containing at least 1 X 106 gametocytes, were lysed
in 40|il of Topoisomerase II assay buffer (). The lysates were cleared of cell debri by
a briefmicrocentrifugation at 4°C. The lysates were split in two, one half was stored
frozen at-70°C and later analysed for the presence of P. falciparum Topoisomerase
II by Western blotting as described in section (2.4.2). To the remaining 20jll1 lysate,
200ng on Kinetoplast DNA (KDNA) was added and the reaction incubated at 37°C
for 30 minutes. The decatenation reaction was stopped by the addition of 0.2
volumes of gel loading dye (25% (v/v) glycerol, 5% (w/v) sarkosyl and 0.0025%
bromophenol blue). The whole reaction contents were loaded on a 1% agarose gel
containing 0.5pg/ml of ethedium bromide and electrophoresed between 50-100V until
the dye front had travelled about 5cm. Linearized, decatenated and non-decatenated
KDNA were also run on the gel and acted as experimental controls. The gel was
visualised by UV-irradiation.
One unit of Topoisomerase II enzyme completely decatenates 200ng of KDNA in 15
minutes at 37°C.
2.4.6 Preparation of Mowiol Mounting Medium
2.4g of MOWIOL®4-88 were added to 6.0g glycerol and solution stirred for lhour.
6.0ml of sterile distilled water were added and the solution stirred for 2 hours. 12ml
of 0.2M Tris-HCL (pH 8.5) were added and the solution further incubated in a 50°C
water bath with occasional stirring. The solution was clarified by centrifugation at




2.5.1 Isolation of DNA
QIAGEN Plasmid DNA Mini and Midi Kits were used to prepare plasmid DNA
from Escherichia coli.
2.5.1.2 Isolation of Plasmodium falciparum genomic DNA
P. falciparum 3D7A was grown in vitro, as described in section 2.3.3, to a culture
parasitemia of at least 5% and parasites were isolated as described in section 2.3.8.
The parasite pellet was resuspended in PBS containing 100pg/ml ofProteinase K and
the resulting suspension incubated at 50°C for 3 hours. The solution was allowed to
cool to room temperature before phenol/chloroform extraction of genomic DNA as
described in section 2.5.1.3.
2.5.1.3 Phenol/chloroform extraction of DNA
DNA was extracted by adding an equal volume of phenol/chloroform/isoamyl alcohol
(25:24:1) pH 8.0, and the resulting suspension mixed vigorously by hand, then
microcentrifuged at 13,500rpm for 1 minute at room temperature. The upper
aqueous phase was transferred to a clean microfuge tube and the sample re-extracted
until the interphase was clear (up to five extractions). The aqueous phase was then
re-extracted against chloroform in order to remove any traces of phenol prior to
ethanol precipitation as described in section 2.5.1.4.
2.5.1.4 Ethanol precipitation
To a DNA solution, a 0.1 volume of 3M sodium acetate (pH 5.2) was added
followed by 2 volumes of ice cold absolute ethanol. The sample was incubated at
-70°C for at least 15 minutes and then micro-centrifuged (13,500rpm, 4°C, 30
minutes) and the pellet washed twice with 70% (v/v) ethanol. The pellet was air-
dried and resuspended in TE (pH 8.0). The DNA was analysed by agarose gel
electrophoresis (section 2.5.9) and UV spectrophotometry.
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2.5.1.5 Minipreparation of plasmid DNA
A single bacterial colony was used to inoculate 5ml of LB medium supplemented
with 50p,g/ml ampicillin and grown at 37°C overnight with shaking. 1.5ml of the
culture was microcentrifuged (13,500rpm, 5 minutes) at room temperature. The
supernatant was discarded and the bacteria pellet resuspended in 250pil of buffer PI
(50mM Tris-HCl, pH 8; lOmM EDTA; 100pg/ml RNase A). 250pl of cell lysis
buffer P2 (200mM NaOH; 1% SDS) was added and the suspension mixed by gently
inverting 4-6 times. 350pl of buffer N3 (1.32M potassium acetate pH 4.8) was
added and the solution mixed gently by inverting 4-6 times. The resulting cloudy
solution was microcentrifuged (13,500rpm, 10 minutes) at room temperature. The
supernatant was applied to a QIAprep column and column microcentrifuged for 1
minute and the flow-through discarded. 500pl of buffer PB was added to the
QIAprep column and the column microcentrifuged for 1 minute. The flow-through
was discarded. 750(il of buffer PE were added to the QIAprep column and the
column microcentrifuged for 1 minute. The flow-through was discarded and the
column microcentrifuged for an additional 2 minutes to in order to remove residual
wash buffer PE. The QIAprep column was placed in a clean microfuge tube and the
DNA eluted by adding 50|il of buffer EB (lOmM Tris-HCl pH 8.5) to the centre of
the QIAprep column, incubating for 1 minute and microcentrifuging for 1 minute.
5pil of the plasmid preparation was analysed by agarose gel electrophoresis (section
2.5.9) and another 5jol quantified by UV spectrophotometry (section 2.5.8). The
remaining plasmid preparation was stored at -20°C until required.
2.5.1.6 Midipreparation of plasmid DNA
A single bacterial colony was used to inoculate 100ml of LB medium supplemented
with lOOjlg/ml ampicillin and grown at 37°C overnight with shaking. 25ml of the
culture was centrifuged (2500g, 4°C, 10 minutes). The supernatant was discarded
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and the bacterial pellet resuspended in 4ml of buffer PI (50mM Tris-HCl, pH 8;
lOmM EDTA; 100)ig/ml RNase A) by vortexing until no cell clumps remained. 4ml
of cell lysis buffer P2 (200mM NaOH; 1% SDS) was added and the suspension
mixed thoroughly but gently by inverting 4-6 times and the suspension incubated for
5 minutes at room temperature. The solution was neutralised by adding 4ml of pre-
chilled buffer P3 (potassium acetate, pH 5.5). The lysate was then poured into the
barrel of a QIAfilter cartridge, with a cap screwed onto the outlet nozzle, and
incubated for 10 minutes at room temperature. Meanwhile, a QIAGEN tip 100 was
equilibrated by applying 4ml of buffer QBT (750mM NaCl; 50mM MOPS, pH 7.0;
15% ethanol; 0.15% Triton X-100) and allowing the column to empty by gravity
flow. The cap was removed from the bottom of the QIAfilter cartridge, a plunger
gently inserted and the cell lysate filtered into the previously equilibrated QIAGEN-
tip 100. The cleared lysate was allowed to enter the resin by gravity flow and the
resin washed twice with 10ml of buffer QC (1M NaCl; 50mM MOPS, pH 7.0; 15%
ethanol). DNA was eluted with 5ml of buffer QF (1.25M NaCl; 50mM Tris-HCl,
pH 8.5 ; 15% ethanol), precipitated with 0.7 volumes of room temperature
isopropanol, then centrifuged (15,000g, 4°C, 30 minutes). The pellet was washed
with 2ml of 70% ethanol, air dried briefly and dissolved in 200)0.1 EB (lOmM Tris-
HCl pH 8.5). 5pl of the plasmid preparation was analysed by agarose gel
electrophoresis (section 2.5.9) and another 5pl quantified by UV spectrophotometry
(section 2.5.8). The remaining plasmid preparation was stored at -20°C until
required.
2.5.1.7 Cloning of PCR fragments
The TOPO TA Cloning® kit (Invitrogen) was used. 1 (ol of pCR®2.1-TOPO®
vector was added to 4pl of PCR product, mixed gently and incubated for 5 minutes at
room temperature. 2\x\ of this solution was added to a vial of TOP 10 One Shot®
cells (provided with the kit) and the resulting suspension mixed gently and incubated
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on ice for 30 minutes. The suspension was heat-shocked for 30 seconds at 42°C
without shaking and immediately placed on ice. 250jixl of room temperature LB
medium was added to the suspension, which was then incubated horizontally at 37°C
for 30 minutes. 20pil of the transformation reaction was spread onto LB plates
supplemented with 50pg/ml of ampicillin and 0.004% X-Gal. The plates were
allowed to dry, inverted and incubated for 18 hours.
2.5.2 Colony screening
2.5.2.1 Blue/white colony selection
To promote full colour development, the plates were transferred to 4°C for 2 hours.
The multiple cloning site of pCR®-TOPO® vector contains the LacZ gene.
Insertion of a DNA fragment into the multiple cloning site facilitates the blue/white
colony colour selection, where white coloured colonies harbour the vector with insert
present. White colonies were randomly picked for further analysis.
2.5.2.2 Double restriction analysis of white colonies
10 randomly selected white colonies were picked and individually resuspended in
5ml ofLB medium containing 50(ig/ml of ampicillin and incubated overnight at 37°C
with agitation. The following day, bacteria were collected, by micro-centrifugation,
and minipreparations of the plasmids prepared as described in section 2.5.1.5.
Double endonuclease restrictions using Xbal and BamHI restriction endonucleases
determined the presence of inserts in the plasmid preparations and were carried out
as described in section 2.5.3. The reaction products were analysed by agarose gel
electrophoresis.
2.5.2.3 PCR analysis of white colonies
The multiple cloning site on pCR®2.1-TOPO® vector is bordered by Ml3 Reverse
primers on one end and Ml3 Forward primers on the other. PCR analysis using
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either Ml3 Forward or the Ml3 Reverse primers and a primer that hydridizes to the
PCR insert determined the orientation of the PCR inserts within the vector. A
standard PCR cocktail containing PCR buffer, dNTPs, Taq polymerase, and either
the Ml3 Forward or Ml3 Reverse primers and a primer that hydridizes to the PCR
insert was made up. 10 white colonies were picked and resuspended individually in
20pl of PCR cocktail. The reaction was incubated for 10 minutes at 94°C in order to
lyse the cells and inactivate nucleases followed by 30 cycles of 94°C for 1 minute,
55°C for 1 minute, and 72°C for 1 minute. A final extension of 72°C for 10 minutes
was followed by incubation at 4°C. The reaction products were analysed by agarose
gel electrophoresis.
2.5.3 Endonuclease restriction
The multiple cloning site (MCS) on pCR®2.1-TOPO® has restriction sites for Xbal
and BamHl endonucleases were located on either sides of the PCR product cloning
site (Figure 1). Therefore, double enzyme endonuclease restrictions, using Xbal and
BamHl endonucleases, were carried out on pCR®2.1-TOPO® isolated from
overnight cultures in order to determine the presence or absence of insert DNA
fragment.
5 units each of Xbal and BamKl endonucleases were added to 5pl of plasmid DNA
and 2jli1 of 10X Buffer 2 (New England Biolabs) and the volume made up to 20pl
with sterile distilled water. The reaction was incubated at 37°C for 2 hours. The
restriction reaction (20pl) was analysed by agarose gel electrophoresis and DNA
fragments, showing the expected molecular weight, purified from the gel (section
2.5.4).
2.5.4 Gel extraction of DNA fragments
QIAquick gel extraction kit (QIAGEN) was used. Gel containing DNA fragments of
interest was placed on a short-wave UV transilluminator and the DNA fragment of
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interest quickly excised from the agarose gel by punching the open end of a sterile
lml blue pipette tip and the gel slice transferred to a microfuge tube and weighed. 3
gel volumes of buffer QG were added and gel dissolved by incubating at 50°C for 10
minutes. 1 gel volume of isopropanol was added, mixed and solution applied to a
QIAquick spin column attached to a 2-ml collection tube. The column was
centrifuged for 1 minute and flow-through discarded. 500pl of buffer QG was added
to the QIAquick column and centrifuged for 1 minute and flow-through discarded.
750pil of buffer PE was added to the QIAquick column and centrifuged for 1 minute
and flow-through discarded. The QIAquick spin column was centrifuged for a
further 1 minute in order to remove residual buffer PE. QIAquick spin column was
transferred to a sterile 1.5ml centrifuge tube and the DNA eluted by adding 30pl of
EB (lOmM Tris-HCl, pH 8.5) to the centre of the QIAquick membrane and the
column centrifuged for 1 minute at maximum speed. The gel purified DNA fragments
were stored at -20°C until required.
2.5.5 Preparation of competent Escherichia coli
A single bacterial colony of XL1 was used to inoculate 5ml of LB medium and
incubated, with agitation, overnight at 37°C. The overnight culture was diluted 1:200
in LB and grown, with aeration, for 2 hours or until growth was just visible. The
bacteria from the overnight cultures were collected by centrifugation (l,500g, 5
minutes, 4°C) and supernatant discarded. The bacterial cell pellet was resuspended
in ice-cold 0.1M CaCl2 and incubated on ice for 20 minutes. The bacteria were
collected by centrifugation and pellet resuspended in 100p.l ice-cold 0.1M CaCl2 and
used immediately for transformation reactions described in section 2.5.7.
2.5.6 Ligations
The pST18 vector, supplied by Roche, has both T7 and SP6 RNA polymerase
transcription start sites. DNA fragments cloned in pST18 can, therefore be
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transcribed and transcripts complementary to both strands of the inserted DNA can
be obtained from the same construct.
The MCS of pST18 has restriction sites for both Xbal and BamRl endonuclueases
(Figure 5.2). pST18 was therefore double restricted using Xbal and BamHl
endonucleases, as described in section 2.5.3, and gel-purified as described in section
2.5.4.
Gel-purified Xbal-BamHl DNA fragments, isolated from pCR®2.1-TOPO®, were
cloned into aXbal and BamHl restricted and gel purified pST18 vector. The ligation
reaction comprised; 5(il of the gel-purified Xbal-BamHI DNA fragment, lp.1 of the
double restricted and gel-purified vector pST18, 1 unit of T4 DNA ligase (Roche),
1 pil of 10X T4 DNA ligase buffer (660mM Tris-HCl, pH 7.6; 66mM MgCl2;
lOOmM DTT; 660mM ATP) at 16°C overnight. A control including all components
except the DNA fragment was also included and treated similarly. The ligation
reaction was either stored at -20°C until required.
2.5.7 Transformations
lOp.1 of the ligation reaction (section 2.5.6) was added to lOOpl of competent XL1
cell suspension and the resulting solution incubated on ice for 1 hour. The cells were
heat-shocked for 90 seconds at 42°C and immediately placed on ice for 2 minutes,
lml ofLB medium (without ampicillin) was added the transformed cells which were
then incubated for 1 hour at 37°C with agitation. The transformed cells were
collected by microcentrifugation (13,000rpm, 1 minute, room temperature) and
resuspended in 1 OOjllI of LB medium supplemented with 50|ag/ml of ampicillin. The
transformed cells were spread on selective medium plates containing 50p,g/ml of
ampicillin, the spread plates allowed to dry, inverted and incubated overnight at
37°C. The following day, 10 colonies were randomly picked and individually
resuspended in 5ml of LB (with ampicillin) and incubated overnight at 37°C with
agitation. Minipreparations of plasmid DNA were carried out (section 2.5.1.5)
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followed by double endonuclease restriction analysis (section 2.5.3). Clones shown
to posses plasmids with inserts having the expected molecular weight were grown up
for midipreparation of plasmid DNA (section 2.5.1.6).
2.5.8 Polymerase Chain Reaction (PCR)
2.5.8.1 Standard PCR
Method used was as described by Saiki et al., 1988 and Innis et al., 1990. Roche
Biochemicals, UK, supplied Taq DNA polymerase, PCR buffer (with Mg2+) and
dNTPs. The PCR was assembled on ice. A typical PCR contained; lOOng template
DNA, 1 unit of Taq DNA polymerase, 200pM dNTPs, lpM gene specific
oligonucleotides primers and IX PCR buffer (1.5mM MgCl2; 500mM KC1; lOOmM
Tris-HCl, pH 9.0; 1% Triton X-100), in a total volume of 50pl. The PCR mixture
was placed in a thermal cycler programmed for an initial denaturation step at 94°C
for 3 minutes followed by 30 cycles of 94°C for 1 minute, 42°C for 1 minute, and
72°C for 1 minute for the actual amplification. A final extension of 72°C for 10
minutes was followed by incubation at 4°C. A tenth of the reaction product was
analysed by agarose gel electrophoresis.
2.5.8.2 PCR Fluorescein labelling
Roche Diagnostics GmbH, Germany supplied PCR Fluorescein labelling Mix. The
PCR Fluorescein labelling Mix is a mixture of the lithium salts of dATP, dCTP,
dTTP, dGTP and fluorescein-12-UTP. This nucleotide mix is used in PCRs and
leads to the direct incorporation of fluorescein-12-UTP into the PCR product. The
PCR for fluorescein labelling was carried out essentially as described for standard
PCR but with two alterations; the fluorescein labelled dNTP mix was used in place of
the unlabelled dNTP mix and the Mg2+ concentration was increased to 4.0mM from
1.5mM used in standard PCR. The PCR programme for amplification was the same
as that used for standard PCR (section 2.5.8.1). A tenth of the fluorescein-labelled
PCR product was analysed by gel electrophoresis without the addition of ethedium
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bromide in order to confirm fluorescein incorporation into the PCR product. The un¬
incorporated fluorescein-labelled nucleotides were removed by ethanol precipitation
of the fluorescein-labelled PCR product and the resulting precipitate resuspended in
50pl of sterile distilled water. The presence of remaining un-incorporated
fluorescein-labelled nucleotides within the precipitated fluorescein-labelled PCR
product was monitored by agarose gel electrophoresis. The fluorescein-labelled PCR
product was used as a probe for the in situ hybrisation described in section 2.7.4.
2.5.9 UV spectrometry
DNA or RNA samples were diluted 1 in 200 with sterile water and analysed on a
Perkin Elmer 115 spectrophotometer set up to scan 200-300nm range. The
concentration of nucleic acid in the samples was deduced from the formula below:
{DNA] pg/ml = absorption at 260nm (A26o) X 50 X dilution factor
{RNA] flg/ml = absorption at 260nm (A26o) X 40 X dilution factor
The relative purity of the sample was determined by calculating the A260/A280 ratio,
where a value of 1.8 or greater indicates that the sample is free of protein
contamination.
2.5.10 Agarose gel electrophoresis
2.5.10.1 Casting agarose gels
Roche Diagnostics and Biochemicals, Germany supplied multi-purpose agarose.
The appropriate amount of agarose (Table 1) was dissolved in IX TBE by heating
the mixture in a microwave oven. The solution was cooled to approximately 60°C
and ethedium bromide added to make a final concentration of 5pg/ml. The molten gel
was poured into the appropriate size casting tray and allowed to solidify at room
temperature.
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Table 1. The relationship between the concentration of agarose and the separation











2.5.10.2 Running of agarose gels
The solidified gel was submerged in 1 X TBE buffer. Samples and DNA size
markers were mixed with a 1 volume of 10 loading buffer. Samples were subjected to
electrophoresis at 5V/cm until sufficient separation of the DNA fragments was
achieved as judged from UV transillumination of the gel.
2.5.10.3 Imaging
Following electrophoresis, nucleic acids on ethedium bromide gel visualised by
placing gel on an UV-transillunminator and a photographed taken using a Mitsubishi
Video processor to heat sensitive film.
2.6 RNA Methods
2.6.1 Isolation of total RNA from P. falciparum
Total RNA was isolated using Total RNA Isolation Reagent (TRIR) commercially
available from Advanced Biotechnologies Ltd, UK. A parasite pellet prepared as
described in section 2.3.8 was re-suspended in 1ml of TRIR and lysed by passage
through a G25 hypodermic needle several times. Homogenate was incubated on ice
for 5 minutes to allow for complete dissociation of nucleoprotein complexes. 200pl
of chloroform was added, sample shaken vigorously for 15 seconds and then
incubated on ice for 5 minutes. The homogenate was microcentrifuged (13,500rpm,
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15 minutes, 4°C) and 4/5th of the upper layer transferred to a fresh microfuge tube.
An equal volume of isopropanol was added, mixed gently and the sample placed on
ice for 10 minutes. The sample was microcentrifuged (13,500rpm, 10 minutes, 4°C),
supernatant carefully removed and the visible RNA pellet washed twice with 1ml of
75% ethanol by microcentrifugation (13,500rpm, 5 minutes, 4°C). The RNA pellet
was briefly air-dried and resuspended in sterile RNase free, DEPC treated, double
distilled water. Purity and concentration of RNA was determined by UV
spectrophotometry (2.5.9) and native agarose gel electrophoresis.
2.6.2 DNase treatment of total parasite RNA
2|ig of total parasite RNA were mixed with 4 units of RQ1 RNase-Free DNase
(Promega) in RQ1 RNase-Free DNase reaction buffer (40mM Tris-HCl, pH 8.0;
lOmM MgS04; ImM CaCl2) and incubated at 37°C for 30 minutes. The reaction
was stopped by the addition of lpl of RQ1 DNase Stop Solution (20mM EGTA)
and the DNase inactivated by heating to 65°C for 10 minutes and the final volume
was made up to 1 OOpl with sterile RNase free, DEPC treated, double distilled water.
RNA re-extracted by adding 200(il of phenol/chloroform/isoamyl alcohol (125:24:1,
pH 4.1) and the resulting suspension mixed vigorously by hand, then
microcentrifuged at 13,500rpm for 1 minute at room temperature. The upper
aqueous phase was transferred to a clean microfuge tube and re-extracted against
chloroform (2.5.1.3) in order to remove any traces of phenol prior to ethanol
precipitation. RNA was ethanol precipitated (2.5.1.4), washed and re-suspended in
1 lpl of DEPC treated, double distilled water and stored at -70°C until required.
2.6.3 1st Strand synthesis reaction
j^erverse-ijTM jst stranci synthesis kit from Advanced Biotechnologies Ltd, UK was
used. 1 jLil of anchored oligo dT (0.5|ag/|il) was added to 11 pil (approximately 2pg) of
DNase treated total parasite RNA, mixed and heated briefly at 70°C for 5 minutes, in
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order to remove any secondary structures in the RNA, and then placed on ice. The
following components were added; 4pl of 5X 1st strand synthesis buffer (), 2pl of
dNTP mix (5mM each of dATP, dCTP, dGTP and dTTP), lpl of M-MLV RTase
(25U/pl) and l|il of RNase inhibitor (5U/pl). A 'no-RT' control was performed
essentially the same way but with the omission of M-MLV RTase. The reaction
components were mixed and incubated at 42°C for 1 hour in order for the cDNA
synthesis reaction to proceed. The M-MLV RTase was inactivated by a further
incubation of the reaction at 75°C for 10 minutes and the reaction products stored at
-20°C until required. 2pl of the 1st strand synthesis reaction was used as template
for standard PCR (2.5.8.1) using gene specific oligonucleotide primers.
2.6.4 RNA denaturing gel electrophoresis
RNA was analysed by electrophoresis on 1% agarose in IX MOPS and 6% (v/v)
formaldehyde prepared as described below.
2.6.4.1 Formaldehyde gel preparation
lg of agarose was added to 10ml of 10X MOPS (section 2.2) and 75ml of sterile
DEPC-treated water, heated to 100°C to dissolve the agarose and allowed to cool to
60°C. In a hood, 16.5ml of 37% (v/v) formaldehyde was added, mixed well and
poured into a casting tray and left to solidify.
2.6.4.2 RNA samples preparation and electrophoresis
RNA sample to be analysed was thawed on ice and mixed with an equal volume of
RNA sample buffer (section 2.2). The sample was denatured by heating to 65°C for
10 minutes and cooled immediately on ice. 0.2 volumes of RNA loading buffer
(section 2.2) were added to the RNA sample before loading onto gel. RNA molecular
weight markers were treated in similar manner but in addition, lpl of a 5mg/ml
ethedium bromide solution was added to the markers before loading onto the
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peripheral wells on the gel. The sample was loaded on a formaldehyde gel submerged
in IX MOPS buffer (running buffer) and electrophoresed at 70V for 2-3 hours.
Approximately, 2pg of total RNA was loaded per well.
2.6.5 Northern blotting
After electrophoresis, the gel was placed on a 'wick' consisting of 2 pieces of
Whatman (3MM) paper cut to the exact width of the gel, but longer, so that the ends
could be submerged in a reservoir containing 20X SSC. The gel was surrounded with
saran wrap. A nylon membrane (Hybond N, Amersham), cut to the exact size of the
gel, was placed on the gel and all air bubbles excluded. 4 pieces of Whatman (3MM)
paper, cut to the exact size of the gel, were wet in 20X SSC and placed on the nylon
membrane. A stack of dry paper towels approximately 10cm high, a glass plate and
a 500g weight were placed on the nylon membrane, and the gel left to transfer
overnight at room temperature.
2.6.6 Digoxigenin RNA labelling
Roche Biochemicals, UK, supplied all reagents used, lpg of the DNA template
(pST18) was linearized at a restriction site upstream of the cloned insert. Either
BamHI or Xba\ restriction endonucleases were used. For single enzyme restrictions,
buffer H (50mM Tris-HCl, lOOmM NaCl, lOmM MgCl2, ImM Dithioerythrythol;
pH 7.5) was used for Xbal endonuclease restrictions (Roche). Buffer B (lOmM Tris-
HCl, lOmM NaCl, 5mM MgCl2, lOOmM Potassium acetate, ImM 2-
Mercaptoethanol; pH 8.0) was used for Bamlil endonuclease restrictions (Roche).
The linearized pST18 was purified by phenol/chloroform extraction, ethanol
precipitated and resuspended in 13pl of sterile RNase free, DEPC treated, double
distilled water. The following reagents were added to the linearized pST18; 2pl of
10XNTP labelling mixture (lOmM each of ATP, CTP, GTP, UTP, and 6.5mM of
DIG-11-UTP, pH 7.5), 2pl of 10X transcription buffer (400mM Tris-HCl, pH 8.0;
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60mM MgCl2; lOOmM dithiothreitol; 20mM spermidine), lp.1 of RNase inhibitor
(40U/pl), and either 2\x\ of SP6 (20U/pl) or T7 (20U/p.l) RNA polymerase. The
reaction components were mixed gently and incubated for 2 hours at 37°C. The
reaction was stopped by adding 2pl of 0.2M EDTA (pH 8.0) and unincorporated
DIG-UTP removed by ethanol precipitation. The RNA pellet was washed with
75% ethanol, dissolved on DEPC-treated water and stored at -70°C until required.
2.6.7 Determination of DIG-RNA labelling efficiency
1 ptl of DIG-labelled RNA, prepared as described above, was spotted on a nylon
membrane and cross-linked to it by placing the membrane on a short-wave UV
transilluminator and exposing it to UV for 45 seconds. The membrane was then
treated as described in section 2.6.10.
2.6.8 Prehybridisation and hyrbridisation
Membrane was covered with saran wrap and the RNA cross-linked to the membrane
by placing the membrane on a short-wave UV transilluminator and exposing it to UV
for 45 seconds. Membrane was then placed in a hybridising tube, with 10ml of pre¬
hybridisation solution (50% (v/v) formamide; 5X SSC; 1% (w/v) blocking reagent;
0.02% (v/v) SDS and 0.1% (w/v) lauryolsarcosine), and incubated for at least 2 hours
at 65°C. Hybridisation solution (typically, 5|al of DIG-labelled RNA in 5ml of pre¬
hybridisation solution) was denatured by heating to 68°C for 10 minutes and placing
on ice. The pre-hybridisation solution was replaced with 5ml of hybridisation
solution and the membrane incubated overnight at 65°C.
2.6.9 Post-hybridisation washes
Following hybridisation, the hybridisation solution was poured into a sterile tube and
stored at -70°C for re-use later. The membrane was washed twice, 15 minutes per
wash, in 2X washing solution (2X SSC; 0.1% (w/v) SDS) at room temperature. The
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membrane was washed twice, 15 minutes per wash, in 0.5X wash solution (0.5X
SSC; 1% (w/v) SDS) wash solution at 65°C.
2.6.10 Colorimetric detection with NBT and BCIP
Following post-hybridisation washes, the membrane was equilibrated with in
washing buffer (lOOmM Maleic acid, pH 7.5; 150mM NaCl; 3% (v/v) Tween® 20)
for 1 minute and then incubated in blocking buffer (lOOmM Maleic acid, pH 7.5;
150mM NaCl; (+20°C); 1% (w/v) blocking reagent) for 30 minutes at room
temperature, with gentle agitation. Blocking buffer was then replaced with antibody
solution comprised of 1:5,000 dilution of Anti-Digoxigenin-AP in blocking buffer and
incubated for 30 minutes, with gentle agitation, at room temperature. The antibody
solution was discarded and the membrane washed twice, 15 minutes per wash, in
washing buffer. Membrane was equilibrated with detection buffer (lOOmM Tris-
HC1, pH 9.5; lOOmM NaCl) for 2 minutes. Meanwhile, colour substrate solution
was prepared by mixing 66pl ofNBT and 33jal of BCIP in 10ml of detection buffer.
The detection buffer was poured off and the membrane incubated in the colour
substrate solution, in the dark, until desired bands were visible. The membrane was
washed in sterile distilled waster in order to prevent over-development.
2.7 In situ hydridisation
Unless otherwise stated the methods used were as described by Levy and
Herrington, 1995.
2.7.1 Microscope glass slide coating
Microscope slides were coated with 3-Amino-propyl-triethoxysilane (APES) to
enhance adhesion. In a fume hood, clean microscope slides were immersed in 100%
acetone for 1-2 minutes. The acetone was drained off and slides immersed in 2%
(v/v) APES in acetone for 5 minutes. The excess solution was drained off and the
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slides washed in running water for 1-2 minutes and then dried overnight at room
temperature. The slides were stored dry and dust-free at room temperature until
required.
2.7.2 Fixation and permeabilization of parasites smears
4% paraformaldehyde fixative was prepared by dissolving the appropriate amount of
paraformaldehyde on hot PBS. The fixative was then cooled rapidly on ice. Thin
films of unsynchronised parasites were prepared on APES-coated microscope glass
slides and air-dried. The slides were immersed in the chilled 4% paraformaldehyde
fixative and incubated for 30 minutes at 4°C. The slides were washed by immersion
in PBS for 5 minutes at 4°C. The slides were immersed in 0.1M Tris-HCl (pH 7.2)
containing 0.25% (v/v) Triton X-100 and 0.25% (v/v) Nonidet P-40 twice for 5
minutes at 4°C. The slides where then rinsed in 0.1M Tris-HCl (pH 7.2) for 5
minutes at 4°C followed by an incubation in 2X SSC for 10 minutes at 4°C. The
slides were air-dried, wrapped in aluminium foil and stored desiccated at -70°C until
required.
2.7.3 Nuclease treatment of thin parasite films
Slides containing fixed and permeabialized parasites smears were removed from -
70°C, and allowed to warm up to room temperature while still wrapped. 11.4cm2
Gene Frame® (Advanced Biotechnologies, UK) with a chamber volume of 300pl,
was attached to slides. 10 units of RQ1 RNase-free DNase (Promega) in 300pl of
RQ1 RNase-free DNase reaction buffer (40mM Tris-HCl, pH 8.0; lOmM MgS04;
ImM CaCl2) was applied to the chamber which was then covered with a plastic
coverslip and the slide incubated at 37°C for 4 hours. A control experiment was
carried out in which slides were incubated with the buffer only, no enzyme. All
slides were incubated at 65°C for 10 minutes in order to inactivate the nuclease and
then rinsed twice, for 5 minutes each, in 2X SSC at room temperature. The slides
were either used immediately or stored desiccated at -70°C until required.
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2.7.4 In situ hybridisation with Fluorescein-labelled probes
Slides containing fixed and permeabialized parasites smears were removed from -
70°C, and allowed to warm up to room temperature while still wrapped. 1cm2 Gene
Frame® (Advanced Biotechnologies, UK) with a cavity volume of 25fil, was
attached to each slide. Probe mix was prepared by mixing 2pl of Fluorescein-labelled
PCR product with 23pl of hybridisation buffer (50% formamide; 2X SSC; 20% (w/v)
Dextran sulphate; 0.2% (w/v) non-fat dried milk). The probe mix was heated to 65°C
for 10 minutes then cooled rapidly on ice and applied to the Gene Frame® chamber
on the microscope glass slide. A plastic cover-slip was carefully placed and firmly
secured on the chamber. The slide was placed on a flat plate thermal cycler and
heated to 65°C for 5 minutes and then incubated at 37°C overnight in the dark.
2.7.5 Detection of in situ signal
All the following incubations were carried out in the dark in order to preserve
fluorescence. Following overnight incubation at 37°C, the chamber was carefully
removed and the slide washed once in 2X SSC for 10 minutes at room temperature.
The slide were washed once in 0.2X SSC for 10 minutes at 37°C and again once in
0.1X SSC for 10 minutes at 37°C. The slide was then incubated in 2X SSC for 5
minutes at room temperature. Parasite nucleus was counter-stained by incubating the
slides in PBS containing 0.1 pg/ml DAPI for 5 minutes at room temperature followed
by a quick rinse in sterile distilled water. The slide was mounted in Mowiol
mounting medium and examined by fluorescence microscopy and the images captured
using a digital camera.
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CHAPTER 3




Studies on DNA synthesis in P. falciparum gametocytes have shown that a
significant amount of DNA is synthesised at the onset of gametocytogenesis with the
DNA content increasing to about 1.8c most likely as a result of DNA amplification
rather than whole genome duplication (Janse et al., 1988).
In this chapter, an attempt to study the pattern of expression of proteins involved in
P. falciparum DNA replication during gametocytogenesis will be described. Indirect
immunofluorescence assays (IFAs) with rabbit polyclonal antisera developed
specifically against recombinant small fragments of PfRfcl, PfRfc2 and PfRfc3
(Douglas J, 1999), PfPcna (Horrocks et al., 1996) and PfTopoII (Cheesman, et al.,
1998) were used. Gametocyte-specific antibodies, mouse anti-Pfs230 (12F10) and
anti-Pfg 27/25 (1H12) monoclonal antibodies were included in the assays in order to
help distinguish between asexual and sexual parasites. These monoclonal antibodies
were kindly donated by Prof. Richard Carter, Institute of Cell Animal and Population
Biology (ICAPB), University of Edinburgh
First, Western analysis on asexual parasite protein extracts using these antisera were
carried out. Although these antisera gave at least one major band at the expected
molecular mass in each case, as indicated by the arrows, several other faint bands
were seen (Figure 3.1). These additional bands might represent degradation products
of the main protein or be proteins that share some similarity with the protein against
which the antiserum was raised. An attempt was first made to immunoaffinity
purify these polyclonal antisera, verifying their purity using Western analysis on
asexual parasite protein extracts before attempting IFAs with gametocytes.
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3.2 Immunoaffinity purification of whole rabbit antisera
3.2.1 Western blots of asexual parasites probed with whole rabbit antiserum
and affinity purified polyclonal antibodies
Total parasite protein (2.4.1) prepared from asexual blood cultures that contained
predominantly trophozoites and schizonts (2.3.3), was size-fractionated on 10%
polyacrylamide gels, blotted and probed with rabbit polyclonal antiserum and the
corresponding affinity purified polyclonal antibodies against PfRfcl, PfRfc2, PfRfc3,
PfPcna and PfTopoII. Figure 3.2 shows the results of this experiments. It can be
seen that affinity purified antisera (lane 2) recognised only one band (indicated by an
arrow), that from which it was extracted. However, by comparing the band
intensities before and after affinity purification, and using them as a measure of
relative amount of antibody present, it appears that affinity purification leads to a
drastic reduction in reacting antibodies. In order to roughly determine the levels of
reacting antibodies present after affinity purification, a series of dilutions of each
whole polyclonal antisera were used to probe asexual parasite protein blots.
3.2.2 Western blots of asexual parasites probed with serial dilutions of whole
antiserum
Dilutions of the whole rabbit polyclonal antisera were prepared and each was used to
probe asexual parasite protein extracts. The aim of this experiment was to determine
what dilution of whole rabbit antisera was needed to produce a band of roughly
comparable intensity with that observed with undiluted affinity purified polyclonal
antibodies. Figure 3.3 shows the results of this experiment. Each lane contained the
same concentration of parasites proteins (2pg/lane) (2.4.2.6). The peripheral lanes to
the extreme left of the blot show bands produced using the whole volume of solution
recovered from the extraction of band specific antibodies along the whole breadth of a
mini-blot (2.4.4). By comparing the band intensities, it can be seen that affinity
purified polyclonal antibodies give similar band intensities as 1:12,800 for PfRfcl,
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1:3,200 for PfRfc2, 1:12,800 for PfRfc3 and 1:12,800 for PfPcna dilution of the
original whole rabbit polyclonal antisera.
3.3 Indirect immunofluorescence assays (IFA)
3.3.1 IFA on asexual parasites using affinity purified polyclonal antibodies
and whole rabbit polyclonal antisera
Indirect double immunofluorescence assays (2.4.3) were carried out on thin films
(2.3.9) of blood smears prepared from unsynchronised cultures (2.3.4) using the
affinity purified polyclonal antibodies (2.4.4) and whole rabbit polyclonal antiserum
against PfRfcl, PfRfc2, PfRfc3 and PfPcna.
IFAs carried out using affinity purified rabbit polyclonal antibodies resulted in very
faint fluorescence (data not shown). However, whole polyclonal antiserum also gave
very faint fluorescence (data not shown) when used for IFAs at the dilutions that
were seen to give similar band intensities to purified polyclonal antibodies on
Western blots, that is, PfRfcl at 1:12,800 (Figure 3.3, lane 6), PfRfc2 at 1:3,200
(Figure 3.3, lane 4), PfRfc3 at 1:12,800, (Figure 3.3, lane 6) and PfPcna at 1:12,800
(Figure 3.3, lane 6) dilution. It was therefore concluded that the purified antibodies
were present at too low a level to be effective. Previous studies on the stage-specific
expression of PfRfcl, PfRfc2 and PfRfc3 (Douglas J, 1999), PfPcna (Horrocks et al.,
1996) and PfTopoII (Cheesman et al., 1998) in the intraerythrocytic cycle have
obtained successful results in IFAs using the same batch of whole rabbit polyclonal
antiserum at 1:80 dilution. The study was therefore continued using diluted rabbit
polyclonal antisera.
3.3.2 Immunofluorescence assays during gametocytogenesis
Thin films (2.3.9) prepared from unsynchronised cultures (2.3.4) containing
gametocytes in various stages of development and asexual parasites were screened
with whole rabbit polyclonal antiserum against PfRfcl, PflRfc2, PfRfc3 and PfPcna
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at 1:80 dilution (2.4.3) and detected with TRITC-conjugated anti-rabbit antibodies.
A mixture of mouse anti-Pfs230 (12F10) at 1:2,500 dilution and anti-Pfg 27/25
(1H12) (1:1,000 dilution) monoclonal antibodies which specifically recognise
gametocytes were included in the assays and detected with FITC-conjugated anti-
mouse antibodies. Anti-gametocyte antibodies helped distinguish between asexual
and sexual parasites.
3.3.2.1 Immunofluorescence assays using anti-PfRfcl polyclonal antiserum
Figure 3.4 shows IFAs carried out using rabbit polyclonal antisera against anti-
PfRfcl. Pre-immune serum treated similarly is shown at the bottom of the figure. It
can be seen that PfRfcl is present throughout gametocytogenesis. By comparing the
DAPI and TRITC signals, fluorescence appears to emanate primarily from the
nuclear region of stages I, II, III and V gametocytes. Stage I and V gametocytes show
the highest intensity of TRITC fluorescence. Diffused fluorescence is observed
throughout the cytoplasm of stage IV gametocytes. No fluorescence was observed
with pre-immune serum.
3.3.2.2 Immunofluorescence assays using anti-PfRfc2 polyclonal
antiserum
Figure 3.5 shows IFAs carried out using rabbit polyclonal antisera against PfRfc2.
Fluorescence can be seen in all the gametocyte developmental stages, suggesting that
PfRfc2 is present throughout gametogenesis. Apart from stage IV gametocytes,
fluorescence appears to primarily emanate from the nuclear region stained by DAPI.
Stage I and II gametocytes appear to have the higher intensity of fluorescence than
the more mature gametocytes. Stage IV gametocyte show a more diffuse fluorescence
throughout their cytoplasm. Fluorescence is distinctly absent from the nucleus of
stage V gametocytes and is mainly located within the cytoplasm. This is in contrast
to PfRfcl where stage V gametocytes show the bright fluorescence located within the
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nucleus. Pre-immune serum was treated similarly but failed to show any
fluorescence.
3.3.2.3 Immunofluorescence assays using anti-PfRfc3 polyclonal antiserum
Figure 3.6 shows IFAs carried out using rabbit polyclonal antisera against PfRfc3.
It can be seen from this figure that PfRfc3 is present in all gametocyte stages. Unlike
PfRfcl and PPRfc2, fluorescence appears to emanate primarily from a spot deep
within the nucleus of all the gametocyte developmental stages. Stage I gametocytes
show significantly higher fluorescence intensity than the rest of the gametocyte
stages. No fluorescence was observed with pre-immune serum.
3.3.2.4 Immunofluorescence assays using anti-PfPcna polyclonal antiserum
Figure 3.7 shows IFAs carried out using rabbit polyclonal antisera against PfPcna.
It can be seen from this figure that all gametocyte stages possess PfPcna.
Fluorescence appears to primarily emanate from the nuclear region, stained by DAPI,
of all the gametocyte stages except stage II gametocytes. Stage V gametocytes have
the highest intensity of fluorescence. Gametocyte stage II and III also show diffuse
cytoplasmic fluorescence. No fluorescence was observed with pre-immune serum.
3.3.2.5 Immunofluorescence assays using anti-PfTopoII polyclonal antiserum
Figure 3.8 shows IFAs carried out using rabbit polyclonal antiserum against
PfTopoII. The figure shows a high intensity of fluorescence, localised primarily in
the nuclear region of all the gametocyte stages, with the exception of stage IV
gametocytes. Stage IV gametocytes show the lowest and most diffuse fluorescence.
Some stage V gametocyte appear to have two centres of fluorescence, one located
within the nuclear region, stained by DAPI, at one end of the parasite and the other




In this chapter, immunoaffinity purification of rabbit polyclonal antisera against
PfiRfcl, PfRfc2, PfRfc3 and PfPcna was successfully carried out as shown by
Western analysis before and after purification. However, the affinity purified
polyclonal antibodies failed to give a significant fluorescence when used to screen
thin films of P. falciparum asexual parasite smears possibly because the reacting
antibodies were present at very low levels. It is possible that during immunoaffmity
purification, not all the antibodies bound to the target protein were eluted hence
leading to low antibody recovery. Success of the elution step would have been
verified by incubating the eluted strip of blot with AP-conjugated anti-rabbit
antibodies followed by NBT/BCIP detection. The use of other more sensitive
detection methods, such as immunogold, may be required if such dilute solutions of
affinity purified antibodies are to be used for the detection and localisation of target
protein in situ.
The immunofluorescence experiments using whole rabbit antiserum raised against
recombinant fragments of PfRfcl, PfRfc2, PfRfc3, PfPcna and PfTopoII proteins
have shown that all five proteins are present throughout gametocytogenesis.
PfRfcl is present throughout gametocytogenesis and is localised primarily in the
nuclear region of stages I, II, III and V gametocytes with stage I and V gametocytes
showing significantly higher levels. In contrast, PfRfcl appears to be present in the
cytoplasm and at lower levels in stage IV gametocytes than in the stages of
gametocytes.
PfRfc2 is also present throughout gametocytogenesis and apart from stage IV
gametocytes, it is primarily located in the nucleus. Stage I and II gametocytes appear
to have the higher levels of PfRfc2 than the other gametocytes. Stage IV gametocytes
have the lowest and most diffuse distribution of PfRfc2. Unlike PfRfcl, stage V
gametocytes appear to have low levels of PfRfc2 and in addition, PfRfc2 is distinctly
absent from the nucleus of stage V gametocytes.
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PfRfc3 is present in all gametocyte stages. Unlike PfRfcl and PfRfc2, PfRfc3 is
distinctly located deep within the nucleus of all the gametocyte developmental
stages. It is possible that PfRfc3 is actually within the nucleolus. It appears to and
remains there throughout gametocytogenesis. Only stage I gametocytes appear to
have higher levels of PfRfc 1 while the rest, including stage IV gametocytes, show
similar levels of expression.
PfPcna is also present throughout gametocytogenesis and is also primarily located in
the nucleus, except, surprisingly, in stage II and to some extent stage III gametocytes
where it appears to be mainly in the cytoplasm. Stage V gametocytes appear to have
significantly high levels of PfPcna.
PfTopoII is also present throughout gametocytogenesis and remains localised within
the nucleus throughout this period with the exception of stage IV gametocytes. The
latter appear to have the lowest levels of PfTopoII and diffuse distribution within
the cytoplasm. Some stage V gametocytes appeared to have higher levels of
PfTopoII than others. The smaller and sausage-shaped, usually male gametocytes,
appear to have significantly higher levels of PfTopoII than the large sickle-shaped
female gametocytes.
In general, all five proteins were seen to be present at higher levels within the nucleus
of stage I and V gametocytes with the exception of PfRfc2 which was distinctly
absent from the nuclear region of stage V gametocytes. Stage IV gametocytes appear
to have the lowest and most diffuse levels ofPfRfcl, PPRfc2, PfRfc3 and PfTopoII.
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Figure 3.1 Western blot analysis of asexual parasite protein extracts probes
with rabbit polyclonal antisera
Total parasite protein prepared from asexual blood cultures that contained
predominantly trophozoites and schizonts was size-fractionated on 10%
polyacrylamide gels, blotted and probed with rabbit polyclonal antiserum against
PfRfcl, PfRfc2, PfRfc3 and PfPcna at 1:200 dilution.
Lane 1 Rabbit polyclonal antiserum
Lane 2 Pre-immune serum




















Figure 3.2 Western blot analysis of asexual parasite protein extract probed
with rabbit polyclonal antisera and affinity purified antibody
Total parasite protein prepared from asexual blood cultures that contained
predominantly trophozoites and schizonts was size-fractionated on 10%
polyacrylamide gels, blotted and probed with rabbit polyclonal antiserum and
affinity purified antibody against PfRfcl, PfRfc2, PfRfc3 and PtPcna.
Lane 1 Rabbit polyclonal antiserum (1:200 Dilution)
Lane 2 Affinity purified polyclonal antibody









Figure 3.3 Western blots of asexual parasites probed with affinity purified
polyclonal antibodies and serial dilutions of whole rabbit antiserum
Dilutions of the whole rabbit polyclonal antisera were prepared and each was used to
probe asexual parasite protein extracts. Each lane contained the same concentration
of parasite proteins (2pg/lane). Lanes 1-6 show results obtained with serial dilutions
of antiserum. Arrow indicates main band.
Lane 1 1:400 dilution
Lane 2 1:800 dilution
Lane 3 1:1,600 dilution
Lane 4 1:3,200 dilution
Lane 5 1:6,400 dilution
Lane 6 1:12,800 dilution
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Figure 3.4 Immunofluorescence assays using anti-PfRfcl polyclonal
antiserum
Thin films prepared from unsynchronised cultures containing gametocytes in various
stages of development and asexual parasites were screened with whole rabbit
polyclonal antiserum against PfRfcl at 1:80 dilution. A mixture of mouse anti-
Pfs230 (12F10) (1:2,500 dilution) and anti-Pfg 27/25 (1H12) (1:1,000 dilution)
monoclonal antibodies, which specifically recognise gametocytes, were included in
the assays in order to distinguish between asexual and sexual parasites. Pre-immune
serum was treated in the same way and is shown at the bottom of the figure.
TRITC-conjugated anti-rabbit antibodies detected cross-reactive antiserum.
FITC-conjugated anti-mouse antibodies detected gametocytes-specific antibodies.
DAPI was used to counter-stain counter-stained the gametocyte nucleus.











Figure 3.5 Immunofluorescence assays using anti-PfRfc2 polyclonal
antiserum
Thin films prepared from unsynchronised cultures containing gametocytes in various
stages of development and asexual parasites were screened with whole rabbit
polyclonal antiserum against PfRfc2 at 1:80 dilution. A mixture of mouse anti-
Pfs230 (12F10) (1:2,500 dilution) and anti-Pfg 27/25 (1H12) (1:1,000 dilution)
monoclonal antibodies, which specifically recognise gametocytes, were included in
the assays in order to distinguish between asexual and sexual parasites. Pre-immune
serum was treated in the same way and is shown at the bottom of the figure.
TRITC-conjugated anti-rabbit antibodies detected cross-reactive antiserum.
FITC-conjugated anti-mouse antibodies detected gametocytes-specific antibodies.
DAPI was used to counter-stain counter-stained the gametocyte nucleus.








Figure 3.6 Immunofluorescence assays using anti-PfRfc3 polyclonal
antiserum
Thin films prepared from unsynchronised cultures containing gametocytes in various
stages of development and asexual parasites were screened with whole rabbit
polyclonal antiserum against PfRfc3 at 1:80 dilution. A mixture of mouse anti-
Pfs230 (12F10) (1:2,500 dilution) and anti-Pfg 27/25 (1H12) (1:1,000 dilution)
monoclonal antibodies, which specifically recognise gametocytes, were included in
the assays in order to distinguish between asexual and sexual parasites. Pre-immune
serum was treated in the same way and is shown at the bottom of the figure.
TRITC-conjugated anti-rabbit antibodies detected cross-reactive antiserum.
FITC-conjugated anti-mouse antibodies detected gametocytes-specific antibodies.
DAPI was used to counter-stain counter-stained the gametocyte nucleus.









Figure 3.7 Immunofluorescence assays using anti-PfPcna polyclonal
antiserum
Thin films prepared from unsynchronised cultures containing gametocytes in various
stages of development and asexual parasites were screened with whole rabbit
polyclonal antiserum against PfPcna at 1:100 dilution. A mixture of mouse anti-
Pfs230 (12F10) (1:2,500 dilution) and anti-Pfg 27/25 (1H12) (1:1,000 dilution)
monoclonal antibodies, which specifically recognise gametocytes, were included in
the assays in order to distinguish between asexual and sexual parasites. Pre-immune
serum was treated in the same way and is shown at the bottom of the figure.
TRITC-conjugated anti-rabbit antibodies detected cross-reactive antiserum.
FITC-conjugated anti-mouse antibodies detected gametocytes-specific antibodies.
DAPI was used to counter-stain counter-stained the gametocyte nucleus.








Figure 3.8 Immunofluorescence assays using anti-PfTopoII polyclonal
antiserum
Thin films prepared from unsynchronised cultures containing gametocytes in various
stages of development and asexual parasites were screened with whole rabbit
polyclonal antiserum against PfTopoII at 1:80 dilution. A mixture of mouse anti-
Pfs230 (12F10) (1:2,500 dilution) and anti-Pfg 27/25 (1H12) (1:1,000 dilution)
monoclonal antibodies, which specifically recognise gametocytes, were included in
the assays in order to distinguish between asexual and sexual parasites. Pre-immune
serum was treated in the same way and is shown at the bottom of the figure.
TRITC-conjugated anti-rabbit antibodies detected cross-reactive antiserum.
FITC-conjugated anti-mouse antibodies detected gametocytes-specific antibodies.
DAPI was used to counter-stain counter-stained the gametocyte nucleus.
GI, II, III, IV and V represent the gametocyte sub-stages.
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RNA aids the transfer of genetic information from genomic DNA to functional
proteins during gene expression. This process is regulated at each step in the
pathway from DNA to RNA to protein. In situ hybridisation (ISH) can be used to
detect both DNA and RNA by the hybridisation of specifically designed nucleic acid
probe sequences to intracellular complementary DNA/RNA sequences. Tissue
morphology is preserved and therefore ISH has become a valuable tool for precise
localisation of nucleic acids in intact cells. RNA ISH enables cell-specific mRNAs to
be separated from the more abundant housekeeping proteins and allows for the
investigation of gene expression and its relationship to cell differentiation. In
contrast, once RNAs have been extracted from tissues or unsynchronised cell
populations for northern blotting or RT-PCR, then information about the site of
synthesis is lost. Therefore, knowledge of the spatial distribution and quantification
of RNAs at the tissue, cellular, and subcellular levels is needed to investigate gene
expression and cell differentiation successfully.
The primary objective of this chapter was to establish a working protocol for RNA
ISH in order to study directly the gene expression patterns and the localisation of
messages during gametocytogenesis in P. falciparum.
RNA ISH on thin films of asexual parasites using fluorescein-labelled gene-specific
DNA probes will be described.
4.2 Fluorescent probes for used in in situ hybridisation experiments
Several genes involved in P. falciparum DNA replication have been isolated and
characterised and include PfRFCl, PfRFC2 and PfRFC3 (Douglas J, 1999), PfiPCNA
(Kilbey et al., 1993), PfTOPO I (Tosh and Kilbey, 1995) PfTOPO II (Cheesman et
<7/., 1994). Northern analysis of total parasite RNA isolated from synchronised
cultures showed that transcripts of these genes accumulate mainly in trophozoites
and schizonts forms of the parasite. Gene-specific Fluorescein-labelled DNA probes
for each gene were generated by PCR using a dNTP mix containing Fluorescein-dUTP
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(2.5.8.2) and a pair of oligonucleotide primers either 500 or lOOObp apart. Two
probes of different lengths were generated for each of the seven genes. It was
assumed that the long probes would have more label incorporated into their sequence
than the shorter probes and therefore be easier to detect in situ. However, this had to
be balanced against the expectation that shorter probes would diffuse more readily
into the parasite and therefore would be detectable in situ due to their high
concentration. Unincorporated fluorescein-dUTP was removed by ethanol
precipitation of the PCR products and subsequent washing in 70% ethanol (2.5.1.4).
Figure 4.1 shows a 1.5% agarose gel of the PCR product using oligonucleotides
primers pairs either 500bp (A) or lOOObp apart (B) before (lane 1) and after (lane 2)
ethanol precipitation.
4.3 Fluorescent in situ hybridisation (FISH)
Both the short (approx. 500bp) and the long (approx. lOOObp) fluorescein-labelled
gene fragments were used in ISH on paraformaldehyde-fixed thin fdms of parasites
prepared from an unsynchronised P. falciparum culture predominantly composed of
trophozoites and schizonts (2.7). In all experiments where the short fluorescein-
labelled gene fragments (approx. 500bp) probes were used, faint or in some cases no
fluorescence was observed (data not shown). However, significantly bright
fluorescence was achieved while using the long fluorescein gene fragments (approx.
lOOObp). The results are shown on Figure 4.2.
PfRFCl probe was 1015bp long and PfRFC2 probe was 974bp long. Both probes
showed pockets of fluorescence on the peripheral regions of schizonts away from the
nuclear region stained by DAPI. The PfRFC3 probe was 614bp long and, in contrast
to PfRFCl and PfRFC2, appeared to show fluorescence emanating from the nuclear
region stained by DAPI. Similarly, the PfPCNA probe (804bp) showed fluorescence
within the nuclear region stained by DAPI.
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PfDNA P0L5, PfTOPO I and PfTOPO II probes all gave strong peripherally located
fluorescence away from the DAPI stained nuclear regions in schizont forms of the
parasites.
Figure 4.3 shows gametocyte at stage III of development probed with PfPCNA.
Fluorescence appears to be located within the nuclear region. Diffuse fluorescence can
also be seen in the cytoplasm.
4.4 FISH on DNase-treated parasite thin films
It was seen important to determine, to some extent, whether the fluorescence
observed above was due to the binding of fluorescein-labelled probe to mRNA or to
genomic DNA. To do this, paraformaldehyde-fixed thin fdms of asexual parasites
were DNase-treated (2.7.3) prior to performing the ISH experiments (2.7.4). Due to
time limitations, this was only attempted for PfTOPO I. The results of this
experiment are shown in Figure 4.4. It can be seen from this figure that DAPI gave
no signal implying that gDNA was almost completely eliminated following DNase-
treatment. It can be seen that fluorescence was still present even after DNase-
treatment. In this case, judging by the morphology, the parasite shown appears to be
either a trophozoite or stage II gametocyte.
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4.5 Conclusion
The result of the fluorescent in situ hybridisation (FISH) experiments described in
this chapter using fluorescein-labelled PfRFCl and PfRFC2 gene fragments showed
pockets of fluorescence on the peripheral regions of schizonts away from the nuclear
region stained by DAPI. However, in contrast to PfRFCl and PfRFC2, PfRFC3 and
PfPCNA appeared to show fluorescence emanating from the nuclear region of
schizonts. PfDNA POLS probes also showed fluorescence coming from the
peripheral regions of the schizonts away from the nuclear region stained by DAPI.
Probes against the topoisomerases, PfTOPO I and PfTOPO II, both gave strong
peripherally located fluorescence away from the DAPI stained nuclear regions in
schizont forms of the parasites. Fluorescence was still observed when the FISH
experiments were repeated using fluorescein-labelled PfTOPO I gene fragments to
probe DNase-treated thin films. However, the distinction between asexual and young
gametocytes (stage I and II) of the parasites was difficult as no markers were used.
Although in situ hybridisation is theoretically particularly well adapted to the study
of gene activity in specific cell types and at different stages in cell and tissue
development, it has proved a difficult technique to operate in several laboratories.
One obvious problem is ensuring that any signals observed are not the result of
residual DNA, others have already been mentioned. These difficulties meant that
there was no time to extend the analysis on each gametocyte developmental stage
using fluorescein-labelled gene fragments developed for the gene of interest.
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Figure 4.1 Agarose gel electrophoresis of Fluorescein PCR products
Panel A Short probes of approximately lOOObp in length
Panel B Long probes of approximately 500bp in length
Lanel PCR product before ethanol precipitation.
Lane 2 PCR product after ethanol precipitation and 70% ethanol wash.
M Molecular weight markers (size in kb)
Arrow shows unincorporated fluorescein-dUTP
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(A)
PfRFCl PfRFC2 PfRFC3 PfPCNA PfTOPO I PfPOLS PfTOPO I
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Figure 4.2 Fluorescence in situ hybridisation on paraformaldehyde-fixed
thin Fdms of asexual parasites
Fluorescein-labelled gene fragments were used to screen paraformaldehyde-fixed thin
films prepared from an unsynchronised P. falciparum culture predominantly











Figure 4.3 Fluorescence in situ hybridisation on a paraformaldehyde-fixed
mixed culture using PfPCNA Fluorescein-labelled probe
A paraformaldehyde-fixed thin film prepared from a young gametocyte culture was
probed with a Fluorescein labelled PfPCNA gene fragment. Parasite nucleus was
counter-stained with DAPI.
Figure 4.4 Fluorescence in situ hybridisation on paraformaldehyde-fixed
and DNase-treated thin film using PfTOPOI Fluorescein-labelled probe
A paraformaldehyde-fixed thin film was prepared from a young gametocyte culture
was treated with DNase and then probed with a Fluorescein-labelled PfTOPOI gene











Several studies on the stage-specific expression of genes involved in DNA replication
during the asexual cycle of P. falciparum have been carried out. Northern analysis
has shown that transcripts of PfRFCl, PfRFC2 and PfRFC3 (Douglas J, 1999),
PfPCNA and PfDNA POL 8 (Horrocks et al., 1996), PfTOPO I (Tosh et al., 1999)
and PfTOPO II (Cheesman et al., 1998) accumulate primarily in the trophozoite stage
of the asexual parasite cycle of P. falciparum. Similarly, the corresponding proteins
have also been shown, by Western analysis, to accumulate in trophozoite stages. It
is at the trophozoite stage of the asexual cycle that DNA synthesis takes place
(Gritzmacher and Reese, 1984; Inselburg and Banyal, 1984).
In this chapter, Western analysis for the presence of PfRfcl, PfRfc2, PfRfc3, PfPcna
and PfTopo II proteins in mature purified gametocytes, free of asexual parasites, will
be described. RNA analysis using of northern and RT-PCR analysis of PfRFCl,
PfRFC2, PfRFC3, PfPCNA, PfDNA POL 8, PfTOPO I and PfTOPO II in mature
purified gametocytes, free of asexual parasites, will also be described. Gametocyte
extracts, for the Western analysis, and total gametocyte RNA, for northern and RT-
PCR analysis, was prepared from the same batch of gametocytes in order to permit
simultaneous detection of specific proteins and their corresponding gene transcripts.
Asexual parasites were used as positive controls.
5.2 Gametocyte culture and experimental conditions
Synchronised gametocyte cultures, free of asexual parasites, were cultivated to
maturity (stage V) (2.3.4), purified on Percoll gradients (2.3.6), checked for absence
of activation (2.3.5) and each gametocyte pellet divided into two parts. Total
parasite protein was extracted from one sub-pellet (2.4.1) and total RNA was
extracted from the second (2.6.1). Similarly, total protein and RNA was prepared
from an asexual parasite culture. Western blot analysis was carried out on the total
parasite protein (2.4.2) using rabbit polyclonal antisera against PfRfcl, PfRfc2,
PfRfc3, PfPcna and PfTopo II. Northern analysis was carried out on the using
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digoxigenin-labelled riboprobes specific for PfRFCl, PfRFC2, PfRFC3, PfPCNA,
PfDNA POL5, PfTOPO I and PfTOPO II (for methods see 2.6.5 to 2.6.11).
Reverse transcriptase Polymerase Chain Reaction (RT-PCR) was carried out in two
steps. DNase-digested total gametocyte RNA was reverse transcribed to make the 1st
strand (cDNA). Small aliquots of the first strand were used as templates for standard
PCR using gene-specific oligonucleotide primers approximately 500bp apart. Total
RNA isolated from asexual parasites was treated in a similar manner and was to act as
a positive control.
5.3 Western analysis of mature gametocytes
Protein extracts were prepared from asexual parasites and mature gametocytes and
ran on 10% NuPAGE gels, transferred onto nitrocellulose and probed with rabbit
polyclonal antisera raised against PfRfcl, PfRfc2, PfRfc3, PfPcna and PfTopo II
(2.4.1 and 2.4.2). Figure 5.1 shows the results of this experiment. Each lane
contained equal amounts of whole parasite cell extracts (lpg/lane). It can be seen
from this figure that mature gametocytes posses all five proteins, PfRfcl, PfRfc2,
PfRfc3, PfPcna and PfTopo II, at relatively similar levels and bearing the same
molecular weight as those detected in asexual parasites (indicated by arrows).
5.4 RNA analysis of mature gametocytes and asexual parasites
5.4.1 The preparation of digoxygenin-labelled gene-specific riboprobes
Approximately lOOObp fragment of each gene was amplified from genomic DNA
(2.5.1.2) by standard PCR (2.5.8.1) using gene specific oligonucleotide primers PCR
(see table 1). For ease of cloning, the PCR product was first cloned into pCR®2.1-
TOPO® using a TOPO TA Cloning® kit (Invitrogen) and subsequently transformed
into OneShot Cells (2.5.1.7). The PCR fragments were later re-cloned into pST18
(Figure 5.2) as BamUl-Xbal fragments and grown in XL1 cells.
Figure 5.3 shows an agarose gel (1.5%) of the products following double restriction
of pST18 with Xbal and BamUl. PfRFC3 (lane 3) and PfDNA POL 8 (lane 5)
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fragments appear to have reduced in size from the initially cloned fragment of
approximately lOOObp to about 300bp for PfRFC3 and 500bp for PfDNA PolS. It
was later discovered that both PfRFC3 and PfDNA POL8 gene fragments used
contained a Xbal restriction site in their sequence.
The vector, pST18, contained transcription start sites for SP6 and T7 on either side
of the multiple cloning site. DIG-labelled RNA fragments were synthesised using
either SP6 or T7, depending on the orientation of the insert DNA fragment (2.6.7).
Incorporation of DIG into the RNA probes was determined as described in section
2.6.8 and the results are shown in Figure 5.4a. From the figure, it can be seen that
DIG had been incorporated into all the seven gene-specific RNA probes. The probes
were detectable by NBT/BCIP colour substrate following cross-reaction with anti-
DIG-Alkaline Phosphatase. These DIG-labelled RNA probes were used in the
northern analysis described below.
However, it must be mentioned that the ability to detect these probes did not
necessarily imply their sensitivity. A more appropriate test of probe sensitivity
would have been carried out by spotting several dilution of the target, in this case
pST18 bearing insert, on a nylon membrane, and probing these spots with a known
amount of the probe.
5.4.2 Northern analysis of mature gametocytes and asexual parasite total
RNA
Figure 5.4b shows the result obtained after probing northern blots, bearing equal
amount of total RNA (2pg/lane) (2.2.5.9) from asexual parasites (lanes marked A)
and gametocytes (lanes marked G), with the gene-specific DIG-labelled RNA probes
shown in Figure 5.3a (section 2.6.5 to 2.6.11). Though faint in appearance, bands of
the expected molecular weight (indicated by arrows) were detected in asexual
parasites (lanes marked A) for PfRFCl (4kb), PfRFC2 (1.6kb), PfRFC3 (1.8kb),
PfPCNA (1.6kb), PfDNA POLS (5.2kb) and PfTOPO II (7 and 8kb). No transcript
was detected for PfiTOPO I in asexual parasites. A blunt arrow indicates the position
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at which the band for the PfTOPO I transcript was expected. In contrast, no bands
were detected in the gametocytes lanes (marked G).
However, PfTOPO I transcripts have previously been detected, by northern analysis
using radio-labelled probes, in total RNA prepared from asexual parasites (Tosh and
Kilbey, 1995; Tosh et al., 1999). DIG-labelled RNA probes were used in this study
and are thought to be as sensitive as radio-labelled DNA probes. It is possible that
using the chemiluminescent substrate CSPD in place of the colour substrate
NBT/BCIP used in this study (2.6.11) could have enhanced the sensitivity of the
DIG-labelled RNA probes, however, CSPD was not available.
5.4.3 Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
5.4.3.1 Detection of the presence of genomic DNA in the total RNA solution
used for RT-PCR analysis
Unlike northern analysis, RT-PCR is very sensitive and almost always able to detect
even minute quantities of genomic DNA (gDNA) within an RNA solution. It is
therefore of paramount importance to reduce the amount of gDNA within a total
RNA solution to undetectable levels. In this study the amount of gDNA was
reduced, initially, by carrying out RNA extraction at an acidic pH of 4.1 (2.6.1) and
then later on by subjecting the total RNA solution to a series of DNase-treatments, at
least two treatments for total gametocyte RNA and four treatments for total asexual
RNA (2.6.2).
The presence on gDNA was analysed by two methods. In the first method, two
aliquots of equal amounts of total RNA were prepared; to one, reverse transcriptase
(RT) was added and to the other, no RT was added. Standard PCR was then carried
out using the Ist strand synthesis reaction product as template and gene-specific
nucleotides as primers. The absence of a product following PCR on the minus-RT
reaction implied that the RNA was not contaminated with detectable gDNA.
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In the second method, a standard PCR was carried out using the 1st strand synthesis
reaction product as template and oligonucleotide primers designed to anneal to the
exon regions on either side of the intron.
Figure 5.5 shows the complete coding sequence of PfRFC3 gene. PfRFC3 contains
an intron of 248bp located at the 5' end of the gene (Figure 4.3, intron in bold letters).
The intron runs from 40bp to 298bp downstream of the proposed start ATG. Two
oligonucleotides were designed complementary to the exons 5' and 3' to the intron.
These were:
Forward oligonucleotide primer F73488, at position 013,
Reverse oligonucleotide primer V7275, at position 427.
In the presence of the intron, these oligonucleotides are (427-13 = 424) 424bp apart.
In the absence of the intron, these oligonucleotide would be (424-250 = 176) 176bp
apart. Therefore, amplification arising from genomic DNA is expected to give a PCR
product of approximately 424bp whereas amplification arising from the amplification
of cDNA, arising from the reverse transcription of mRNA, should give a PCR
product of 176bp, a size difference of 248bp showing the absence of the intron.
5.4.3.1 RT-PCR analysis of total RNA from asexual parasites
First strand synthesis reaction (2.6.4) was carried out on 2|tg each of DNase-treated
total RNA (2.6.3) from asexual parasites and gametocytes; aliquoted from the same
batch of total RNA used in the northern analysis described above. A control
experiment without the addition of Reverse transcriptase was also carried out. The
first strand synthesis reaction product was used as a template for standard PCR
using gene-specific oligonucleotide primers approximately 500bp apart.
Figure 5.6 shows RT-PCR results obtained using asexual parasite RNA. All seven
of the DNA replication genes, PfRFCl, PfRFC2, PfRFC3, PfPCNA, PfDNA POL5,
PfTOPO I and PfTOPO II. This findings are consistent with the result obtained
from the northern analysis of the same total asexual RNA shown previously (Figure
5.3b), with the exception of PfTOPO I which was not detected on northern blots. It
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is possible that failure to detect PfTOPO I transcripts in the asexual RNA by
northern analysis was due to very low levels of transcripts detectable only by the
more sensitive RT-PCR analysis.
5.4.3.2 RT-PCR analysis of total RNA from mature gametocyte
Figure 5.7 shows that RT-PCR results obtained using gametocyte RNA. From
these results, it can be seen that gametocytes express, PfRFC2, PfRFC3, PfPCNA,
PflDNA POLS and PfTOPO I. This is in contrast to the results obtained following
northern analysis of the same RNA (Figure 5.3) where only very faint bands were
detected. Flowever, no RT-PCR products were obtained when PfRFCl and
PfTOPO II oligonucleotides were used. This suggests that messages for these two
genes are not present in mature gametocytes. However, while northern analysis was
not able to detect transcripts of PfTOPO I in the gametocyte RNA, a product was
obtained with RT-PCR. This is similar to the result found with asexual parasite
RNA, and suggests that the levels of the PfTOPO I transcript in both asexual and
gametocyte RNA was very low and detectable only by RT-PCR.
It is very important to stress that in both asexual and gametocyte RT-PCRs, the
minus RT control experiments gave no products after PCR. In addition, there was an
approximately 250bp size difference between the PCR products obtained with
gDNA and RT-PCR using the same PfRFC3 oligonucleotide primer pairs F73488 and
V7275. This suggests that the RNA used in the RT-PCR reaction was not
contaminated with detectable gDNA and that the products observed in the 'RT-plus'
lanes truly arise from the amplification of cDNA and not contaminating gDNA.
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5.6 Conclusion
Western analysis has shown that PfRfcl, PfRfe2, PfRfe3, PfPcna and PfTopoII are
present in mature gametocytes at similar levels and bear the same molecular mass as
in asexual parasites.
Transcripts of PfRFCl, PfRFC2, PfRFC3, PfPCNA, PfDNA POL8, PfTOPO I and
PfTOPO II were difficult to detect in mature gametocyte total RNA following
northern analysis. It is possible that the method used in this study was not sensitive
enough to determine the presence or absence of these transcripts. It would be
worthwhile to repeat the northern analysis of total gametocyte RNA but this time
use radio-labelled RNA probes.
In contrast, RT-PCR carried out on the same pool of RNA used in the northern
analysis, was able to detect the presence of PfRFC2, PfRFC3, PfPCNA, PfDNA
POLS and PfTOPO I transcripts in mature gametocytes. However, RT-PCR did not
detect the presence of PfRFCl and PfTOPO II transcripts. In the positive control
RT-PCR experiments using asexual parasite RNA, all seven gene transcripts were
detected. In this respect, the absence of PfRFCl and PfTOPO II in the total
gametocyte RNA is further evidence that it was free of contamination with asexual
parasite RNA. Stringent controls using 'RT-minus' and intron-containing genes
eliminated the possibility that the RT-PCR results were invalidated by contamination
of the RNA with genomic DNA.
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Figure 5.1 Western analysis of asexual parasites and mature gametocytes
protein extracts
Protein extracts were prepared from unsynchronised asexual parasites and mature
gametocytes were size separated on 10% NuPAGE gels, transferred onto
nitrocellulose and probed with rabbit polyclonal antisera raised against PfRfcl,
PfRfc2, PfRfc3, PfPcna and PfTopoII. Each lane contained equal amounts of whole
parasite cell extracts (lpg/lane). Arrows indicate the position of protein.
Lane A Asexual parasite protein extract
Lane G Mature gametocyte protein extract
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Figure 5.3 Double restriction of pST18 with Xbal and BamHl.
Approximately lOOObp fragment of each gene was amplified from genomic DNA by
standard PCR using gene specific oligonucleotide primers. PCR product was first
cloned into pCR®2.1-TOPO® and later re-cloned into pST18 as BamHl-Xbal
fragments. pST18 was double restricted with BamHl and Xbal and the reaction






























Northern analysis of mature gametocytes and asexual parasite total
(A) Confirmation of DIG incorporation into RNA probes
Incorporation ofDIG into the RNA probes was confirmed by placing a small amount
of RNA probe onto a nylon membrane followed by UV cross-linking. The probes
were detected by NBT/BCIP colour substrate deposition following reaction with
anti-DIG-Alkaline Phosphatase antibody. These DIG-labelled RNA probes were
used in the northern analysis described in B.
(B) Northern analysis of mature gametocytes and asexual parasite total
RNA using DIG-labelled gene-specific riboprobes
Northern blots, bearing equal amount of total RNA (2pg/lane) from asexual parasites
and gametocytes were probed with gene-specific DIG-labelled RNA probes shown in
Figure 5.4A. Hybridised probes were detected by NBT/BCIP colour substrate
deposition following cross-reaction with anti-DIG-Alkaline Phosphatase.
Lane G Mature gametocyte total RNA
Lane A Asexual parasite total RNA
Sharp arrows indicate the major bands detected.
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Figure 5.5 Complete nucleotide sequence of PfRFC3
The location and sequence of the synthetic oligonucleotide primers used in the RT-
PCR analysis of parsasite RNA are shown.
PfRFC3 contains an intron of 248bp located at the 5' end of the gene; intron in bold
letters. Two oligonucleotides were designed complementary to the exons 5' and 3' to
the intron. These were:
Forward oligonucleotide primer F73488, at position 013,
Reverse oligonucleotide primer V7275, at position 427.
In the presence of the intron, these oligonucleotides are (427-13 = 424) 424bp apart.
In the absence of the intron, these oligonucleotide would be (424-250 = 176) 176bp
apart.
The arrows point in the 5' to 3' direction of the sense and antisense strands. The




1 ATGACCGAAG TTGAACAACA AAGAGGAAGT GlAACTAACCC CATGGGTATA TAGAAAAGAT
F 73488
61 TACGAATGAT TATATAAAAA GAGTTATATT TTTTATATAT ATGAAAATGT GTATTATTAT
121 AAATTATATT TTGATTTGTT TCCATTTATA TATAATAAAA TGAGAAATGG AATTATATAT
181 ATATATATAT ATATATATAT ATATTTATTT ATCTAATTTT TGAACACTTG TAATATTTGT
241 TGAACAAAAA TAGTCATACA TATATTATTT TTAATTTATA TTTTTTTTTT TATTTTAGGT
301 TGAAAAATAT AGACCAAATG TACTAAATGA TATAATATCG CATGAACAAG TAATATCAAC
361 TATTAAAAGA TTCGTTCAGA AAGGTGAGTT ACCACATTTA CTTTTACATG GTCCCCCAGG
V7275
421 |TACAGGG[AAA ACGTCTACGA TATTGGCTGT GTGTAAAGAA TTATATGGAG ATAAGAGAAG
481 TTCATTTGTT TTAGAATTGA ATGCTTCTGA TGATAGAGGT ATAAACGTTA TTCGTGATCA
541 AATAAAAACA TTTGCTGAAT CAAAAAATCA TTATACAACA TGTGAAAAAA CAACTTTAAA
601 ATTAATTATT TTAGATGAAG CAGATCATAT GACATATCCT GCTCAAAACG CTATGAGAAG
661 GATTATGGAG AACTATGCTA AAAATGTGCG TTTTTGTTTG TTATGTAATT ATGTAAATAA
721 AATAACTCCA GCAATACAAT CTAGATGTAC GGCTTTTCGT TTTGCCCCTT TAAAAAAAGA
781 ATATATGAAA AATAAAGCAC TAGATATAGC AAAATCTGAG AATGTAAATC TAACTGAAGG
841 AGGAATAGAT AGTCTTATAC GTGTAGGACA TGGAGATATG AGAAGAATTT TAAATTGTTT
901 ACAAGTAGTA TCATTAAGTC ATAAAAATCT TGTCATTGAT GAAAATGTTA TTTTATCAAC
961 ATTAGATATC CCATTACCTA GTGAAACCAA GAAAATATTG GAATATTTTA CAAAAGGTTC
1021 TATAAAAGAA TCATACGAAT TTGTTAGTAA TTTACAATAT GATAAAGGAT ATTCAACAAA
1081 AGATATTATG ATGTGTTTAT ATGAATCAGT TTTAACATAT GATTTCCCTG ATTCGGCTTT
1141 TTGTCTTCTA CTTAAAAATT TTGGTGAAAT AGAAGAAAGA TGTTCTTCTG GAGCTAGCGA
1201 ACAAATTACT TTATCTGCTT TAATTAGTGC ATTCGTAGAA TTTCGAACAG AACTTTTCAA
1261 ATTAAAATAT GATATGAGCA ACATATAA
STOP
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Figure 5.6 RT-PCR analysis of total RNA from asexual parasites
First strand synthesis reaction was carried out on 2(ig each of DNase-treated total
RNA from asexual parasites; aliquoted from the same batch of total RNA used in the
northern analysis described above. A control experiment without the addition of
Reverse transcriptase was also carried out. The first strand synthesis reaction
product was used as a template for standard PCR using gene-specific oligonucleotide
primers approximately 500bp apart.
+ PCR on 1st strand synthesis reaction in which RT was added.
PCR on 1st strand synthesis reaction in which no RT was added




Figure 5.7 RT-PCR analysis of total RNA from mature gametocytes
First strand synthesis reaction was carried out on 2pg each of DNase-treated total
RNA from mature gametocytes; aliquoted from the same batch of total RNA used in
the northern analysis described above. A control experiment without the addition of
Reverse transcriptase was also carried out. The first strand synthesis reaction
product was used as a template for standard PCR using gene-specific oligonucleotide
primers approximately 500bp apart.
+ PCR on 1st strand synthesis reaction in which RT was added.
PCR on 1st strand synthesis reaction in which no RT was added











GAMETOGENESIS AND THE DNA REPLICATION APPARATUS
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6.1 Introduction
In the previous chapter, it was shown, by Western analysis, that PfRfcl, PfRfc2,
PfRfc3, PfPcna and PfTopo II proteins were present in mature gametocytes before
activation. It was also shown, by RT-PCR, that gene transcripts for PfRFC2,
PfRFC3, PfPCNA, PfDNA POL 8 and PfTOPO I were present in mature inactivated
gametocytes however, PfRFCl and PfTOPO II transcripts were not detected.
By extension of the result obtained in the previous chapter, the components of the
DNA replication apparatus were analysed during the first fifteen minutes of
gametogenesis by Western analysis, to follow the protein levels, and simultaneously
by RT-PCR, to check for the lack of, or continued presence of gene transcripts of
PfRfcl, PfRfc2, PfRfc3, PfPcna, PfDNA PolS, PfTopol and PfTopoII proteins.
6.2 Gametocyte culture and experimental conditions
In the experiments described in this chapter, it was critical that the gametocyte
cultures used were to be as free of asexual parasite as possible. In order to achieve
this, gametocyte cultures grown in CCMA (2.2) were either depleted of asexual
parasites using a series of sorbitol treatments (Lambros and Vanderberg, 1979) or
treated with GluNAc supplemented CCMA (Ponnudurai et al., 1986). Each set of
cultures was tested for its ability to activate (2.3.5) and the gametocytes concentrated
and purified by Percoll gradient centrifugation (2.3.6). Gametogenesis was induced
(2.3.7) and pellets from each set, were divided into two portions to enable the
simultaneous assays of protein and mRNA by Western blotting and RT-PCR
analysis, respectively.
Another batch of gametocytes, grown entirely in CCMS and depleted of asexual
parasites by GluNAc treatment, was treated similarly. Gametocytes grown in
CCMS, when resuspended in GSM, activate and progress on to exflagellate ten to 15
minutes after induction of gametogenesis. However, gametocytes grown entirely in
CCMA activate but do not progress on to exflagellate. The aim of including this set
of gametocytes was to determine whether the profiles of DNA replication proteins
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and their transcripts during gametogenesis were different in gametocytes that retained
the ability to exflagellate and those that had lost it.
6.3 Western analysis of during gametogenesis
The gametocytes used in the Western analysis experiments were grown entirely in
CCMA synchronised and depleted of asexual parasites by GluNAc treatment after
the onset of gametocytogenesis (2.3.4). These gametocytes, when resuspended in
GSM, rounded up (activated) but did not progress on to exflagellate. Figure 6.1
shows a Coomassie stained SDS-PAGE gel of protein extracts prepared from
gametocyte pellets before and after activation, at 5 minute intervals (2.3.7). From
this figure, it can be seen that each lane had similar amounts of total gametocyte
extracts loaded (lp.g/lane). Several sets of similar gels were prepared, blotted and
probed with rabbit polyclonal antisera against PfRfcl, PfRfc2, PfRfc3, PfPcna and
PfTopoII (below).
Figure 6.2a, b, c, d and e show Western blot analysis of gametocyte extracts before
and after activation. From each of these figures, it can be seen that PfRfcl, PfRfc3,
PfPcna and PfTopoII protein levels did not change markedly throughout
gametogenesis, as judged from the similar band intensities (arrows). However,
PfRfc2 appear to increase after 5 minutes of activation and then gradually decrease as
gametogenesis progresses.
Similar results were observed when CCMA-grown and sorbitol-treated or CCMS-
grown and GluNAc-treated gametocytes were analysed by Western blotting (data not
shown).
6.4 RT-PCR analysis of gametogenesis
6.4.1 RT-PCR analysis of CCMA-grown and GIuNAc-treated gametocytes
Figure 6.3 shows an RT-PCR analysis of total RNA prepared from the second set
of twin pellets whose protein profile and Western analysis are shown on Figure 6.1
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and 6.2a-e. Panel A shows RT-PCR analysis carried out using gene-specific
oligonucleotide primers on 1st strand synthesised from total RNA isolated from the
timed gametogenesis experiments. Transcripts for PfRFC2, PfRFC3, PfPCNA,
PfDNA POL5 and PfTOPO I are detected in mature gametocytes before and after
activation. Both PfRFCl and PfTOPO II mRNA appear not to be present in mature
gametocytes and are not detected even after activation. This is consistent with the
findings in the previous chapter where PfRFCl and PfTOPO II transcripts were not
detected in mature inactivated gametocytes.
As mentioned earlier, PfRFC3 contains an intron of 250bp and was used to control
for the absence of genomic DNA in the RNA samples. In Figure 6.3, the PfRFC3
panel shows the size difference in the PCR product obtained following the use of
gDNA as template and when the 1st strand synthesis reaction product was used, is
roughly 250bp; the size of the intron. This implies that the products seen on the
'RT-plus' (marked +) lanes arise from amplification of cDNA derived from mRNA.
This shows that the total RNA used (Panel B) in each case was free of detectable
gDNA and that the results can be taken to reflect the true gene expression patterns
during gametogenesis. In addition, the 'minus-RT' control gave no products
following PCR although the positive controls using gDNA (lanes marked C)
confirmed that the oligonucleotide primers function.
6.4.2 RT-PCR analysis of CCMS-grown and GluNAc-treated gametocytes
Figure 6.4 shows the RT-PCR analysis of CCMS-grown and GluNAc-treated
gametocytes. Panel A shows the RT-PCR results while Panel B shows a sample ran
from the pool of total RNA used for the RT-PCR experiments. The results in this
figure are similar to those seen in Figure 6.3 for gametocytes grown in CCMA and
treated with GluNAc to eliminate asexual parasites.
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6.4.3 RT-PCR analysis of CCMA-grown and sorbitol-treated gametocytes
Figure 6.5 shows RT-PCR analysis of total RNA prepared from CCMA-grown
gametocytes and sorbitol-treated gametocytes before and during gametogenesis.
Panel A shows the RT-PCR results while Panel B shows a sample ran from the
pool of total RNA used for the RT-PCR experiments. From Panel A, it can be seen
all seven gene transcripts, PfRFCl, PfRFC2, PfRFC3, PfPCNA, PfDNA POLS,
PfTOPO I and PfTOPO II, were detected. PfRFCl and PfTopo II were previously
not detected in CCMS-grown and GluNAc-treated gametocytes (see Figure 6.4). The
size difference observed in PfRFC3 between the control, gDNA as template, and the
RT-PCR product suggests that the total RNA used in each time point of
gametogenesis was free of detectable gDNA. In addition, the minus RT control gave
no products following PCR, further implying that signals seen in the RT-PCR arise
from mRNA.
6.5 Topoisomerase II activity during gametogenesis
So far, the presence immunofluorescence assays and Western blotting analysis has
confirmed the presence of PfRfcl, PfRfc2, PfRfc3, PfPcna and PfTopoII throughout
gametocytogenesis and gametogenesis. However, DNA synthesis has only been
confirmed to take place at the onset of gametocytogenesis and gametogenesis. This
implies that the presence of components of the DNA replication apparatus does not
necessarily mean that DNA synthesis is actively taking place as some components of
the DNA replication apparatus may be present but not active. It is important,
therefore, to carry out activity assays of some these proteins. At present, PfTopol
and PfTopoII activities can be assayed in vitro. In this study, the activity of
PfTopoII was followed before and after activation.
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6.5.1 Western analysis of gametogenesis extracts used for the PfTopoII
activity assay
Gametocyte cultures, synchronised and free of asexual parasites by treatment with
GluNAc, were cultivated to maturity (2.3.4), concentrated and purified on Percoll
gradients (2.3.6) and pellet tested for activation (2.3.5) and divided into triplets. One
pellet was stored and represented mature inactivated gametocytes. Gametogenesis
was induced in the remaining two pellets one pellet collected immediately after
induction and the other five minutes later (2.3.7). Protein extracts were prepared
(2.4.5) from each of the pellets and triplicate sets of the ran on a 10% NuPAGE gel.
Part of the gel containing one set of gametogenesis protein extracts was stained with
Coomassie stain and is shown on Figure 6.6. From this figure, it can be seen that
each lane contained similar amounts ofprotein extracts.
The remaining two sets were transferred onto nitrocellulose and probed with rabbit
polyclonal antiserum against PfTopoII and rabbit pre-immune serum. The results are
shown on Figure 6.7. Judging from the intensity of the triplets bands, it is apparent
that the levels ofPfTopoII remain unchanged as gametogenesis progressed.
6.5.2 Decatenation assay for the detection of PiTopoII activity in
gametogenesis extracts
Type II topoisomerase is able to cleave both strands of a duplex DNA and hence can
resolve catenated DNAs such as Crithidia fasciculata kinetoplast DNA (kDNA)
which consists of mini and maxicircles (Marini et al., 1980). Decatenation of kDNA
by type II topoisomerases results in the formation of nicked open circular (OC) and
relaxed or covalently closed circular (CCC) decatenated kDNA. When the reaction
product are run on an agarose gel, the CCC decatenated kDNA migrates fastest
followed by the OC decatenated kDNA. Catenated kDNA is too dense and remains
in the well. Linearized kDNA runs between CCC and OC decatenated and indicates
DNase activity.
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Figure 6.8 shows the decatenation activity, attributed to PfTopo II, in gametocyte
protein extracts prepared before and after activation. The presence of OC and CCC
decatenated kDNA implies that there is some level of decatenation activity in mature
inactivated gametocytes (I) though most of the kDNA input is still retained in the
well. The decatenation activity can be seen to clearly increase immediately after
activation (AO) as more kDNA is released from the well. The decatenation activity is
highest five minutes after activation (A5) when all the input kDNA can be seen to
have been released from the well.
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6.6 Conclusion
Western blot analysis of gametocyte protein extracts before and after activation
showed no significant changes in the levels of PfRfcl, PfRfc3, PfPcna and PfTopoII
protein throughout gametogenesis, as judged from the similar band intensities.
However, PfRfc2 increased within five minutes of activation and then decreased
progressively as gametogenesis progressed. In the IFA results shown earlier, PfRfc2
was seen to be distinctly absent from the nucleus of stage V gametocytes. Taken
together, the IFA and Western analysis results on the expression patterns of PfRfc2
in mature gametocytes before and after activation, appear to be different from that of
the other DNA replication proteins tested and in particular, that of PfRfcl and
PfRfc3. It is possible that PfRfc2 may be actively synthesised and transported to
the nucleus following activation of mature gametocytes. However, further
experiments, such as the in situ detection of PfRfc2 during gametogenesis, require to
be carried out in order to get to a better understanding of the role of PfRfc2 during
gametogenesis.
Analysis of total gametocyte RNA using RT-PCR detected the presence of
transcripts of PfRFC2, PfRFC3, PfPCNA, PfDNA POL8, PfTOPO I and PfTOPO
II throughout gametogenesis. However, PfRFCl and PfTOPO II transcripts were
not detected. Similar Western and RT-PCR results were obtained regardless of
whether the mature gametocytes were capable of exflagellating (CCMS-grown) or not
(CCMA-grown). However, PfRFCl and PfTOPO II transcripts were only detected
in sorbitol treated gametocytes, possibly indicating the presence of some asexual
parasites.
Topoisomerase II activity was assayed in gametocyte protein extracts prepared
during the first 5 minutes of gametogenesis. Decatenation activity assays showed
that topoisomerase II activity, though present in mature inactivated gametocytes,
progressively increased during gametogenesis.
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Figure 6.1 Coomassie stained gel of protein extracts prepared from mature
gametocyte pellets before and after activation
Mature gametocytes were grown entirely in CCMA, synchronised and depleted of
asexual parasites by GluNAc treatment. These gametocytes were purified and
concentrated on Percoll gradients and divided into four equal portions. Three of the
portions were activated by resuspension in GSM and the gametogenesis stopped at
5 minutes intervals. Each of the four portions was split into two. Total RNA was
prepared from one set and total protein extract from the other set. Equal volumes of
parasite extracts were size separated on 10% NuPAGE gels and stained with
Coomassie Blue (2.4.2.2).
Lane I Mature gametocytes before activation
Lane A5 Mature gametocytes 5 minutes after activation
Lane A10 Mature gametocytes 10 minutes after activation
Lane A15 Mature gametocytes 15 minutes after activation
Positions ofmolecular weight markers are indicated (New England Biolabs)
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Figure 6.2 Western blot analysis of protein extracts prepared from
gametocyte pellets before and after activation
A anti PfRfcl rabbit polyclonal antiserum at 1:200 dilution
B anti PfRfc2 rabbit polyclonal antiserum at 1:200 dilution
C anti PfRfc3 rabbit polyclonal antiserum at 1:200 dilution
D anti PfPcna rabbit polyclonal antiserum at 1:1000 dilution
E anti PfTopoII rabbit polyclonal antiserum at 1:500 dilution
Lane I Mature gametocytes before activation
Lane A5 Mature gametocytes 5 minutes after activation
Lane A10 Mature gametocytes 10 minutes after activation
Lane A15 Mature gametocytes 15 minutes after activation
Lane M Molecular weight markers (New England Biolabs)
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Figure 6.3 RT-PCR analysis of CCMA-grown and GluNAc-treated
gametocytes
Total RNA was prepared from the second set of twin pellets whose protein profile
and Western analysis are shown in Figure 6.1 and 6.2a-e. RT-PCR analysis carried
out using gene-specific oligonucleotide primers on 1 st strand synthesised from total
RNA isolated from the timed gametogenesis experiments. PCR products were
analysed on 2% agarose gels.
A Agarose gel of the RT-PCR products
B A sample of the RNA used for the initial 1st strand synthesis reaction
Lane I Mature gametocytes before activation
Lane A5 Mature gametocytes 5 minutes after activation
Lane A10 Mature gametocytes 10 minutes after activation
Lane A15 Mature gametocytes 15 minutes after activation
M Molecular weight markers in kilobases (Ambion)
+ PCR on 1st strand synthesis reaction in which RT was added.
PCR on 1st strand synthesis reaction in which no RT was added





















Figure 6.4 RT-PCR analysis of CCMS-grown and GluNAc-treated
gametocytes
Mature gametocytes were grown entirely in CCMS, synchronised and depleted of
asexual parasites by GluNAc treatment. These gametocytes were purified and
concentrated on Percoll gradients and divided into four equal portions. Three of the
portions were activated by resuspension in GSM and the gametogenesis stopped at
5 minutes intervals. Each of the four portions was split into two. Total protein
extract prepared from one set and total RNA from the other set. RT-PCR analysis
carried out using gene-specific oligonucleotide primers on 1st strand synthesised from
total RNA isolated from the timed gametogenesis experiments. PCR products were
analysed on 2% agarose gels.
A Agarose gel of the RT-PCR products
B A sample of the RNA used for the initial 1st strand synthesis reaction
Lane I Mature gametocytes before activation
Lane A5 Mature gametocytes 5 minutes after activation
Lane A10 Mature gametocytes 10 minutes after activation
Lane A15 Mature gametocytes 15 minutes after activation
M Molecular weight markers in kilobases (Ambion)
+ PCR on 1st strand synthesis reaction in which RT was added.
PCR on 1st strand synthesis reaction in which no RT was added
C PCR on gDNA using the same set of primers
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Figure 6.5 RT-PCR analysis of CCMA-grown and Sorbitol-treated
gametocytes
Mature gametocytes were grown entirely in CCMA, synchronised and depleted of
asexual parasites by sorbitol treatment. These gametocytes were purified and
concentrated on Percoll gradients and divided into four equal portions. Three of the
portions were activated by resuspension in GSM and the gametogenesis stopped at
5 minutes intervals. Each of the four portions was split into two. Total protein
extract prepared from one set and total RNA from the other set. RT-PCR analysis
carried out using gene-specific oligonucleotide primers on 1st strand synthesised from
total RNA isolated from the timed gametogenesis experiments. PCR products were
analysed on 2% agarose gels.
A Agarose gel of the RT-PCR products
B A sample of the RNA used for the initial 1st strand synthesis reaction
Lane I Mature gametocytes before activation
Lane A5 Mature gametocytes 5 minutes after activation
Lane A10 Mature gametocytes 10 minutes after activation
Lane A15 Mature gametocytes 15 minutes after activation
M Molecular weight markers in kilobases (Ambion)
+ PCR on 1st strand synthesis reaction in which RT was added.
PCR on 1st strand synthesis reaction in which no RT was added
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Figure 6.6 Coomassie stained gel of protein extracts prepared from mature
gametocyte pellets before and after activation
Mature gametocytes were grown entirely in CCMA, synchronised and depleted of
asexual parasites by GluNAc treatment. These gametocytes were purified and
concentrated on Percoll gradients and divided into three equal portions. Two of the
portions were activated by resuspension in GSM and the gametogenesis stopped at
5 minutes intervals. Total protein extract from each pellet and equal volumes of
extracts were size separated on 10% NuPAGE gels and stained with Coomassie Blue.
Lane I Mature gametocytes before activation
Lane AO Mature gametocytes immediately after activation
Lane A5 Mature gametocytes 5 minutes after activation













Figure 6.7 Western blot analysis of protein extracts prepared from
gametocyte pellets before and after activation
Western blots containing equal amounts of extracts prepared from gametocyte pellets
before and after activation were probed with anti-PfTopoII rabbit polyclonal
antiserum at 1:500 dilution.
Lane I Mature gametocytes before activation.
Lane AO Mature gametocytes immediately after activation.
Lane A5 Mature gametocytes 5 minutes after activation.
The extracts probed here were aliquoted from the same set used in Figure 6.6.
Figure 6.8 Decatenation activity assays in gametocyte protein extracts
prepared before and after activation.
Decatenation activity assays using gametocyte extracts prepared from gametocytes
before and after activation. The same set of extracts shown in Figure 6.6 and 6.7
were used.
Lanes as above. I', AO' and A5' are negative controls with extract but without
kDNA.
Controls
K Catenated Kinetoplast DNA (kDNA)
D Decatenated kinetoplast DNA
L Linear kinetoplast DNA
Arrows show the position of;
OC Open circular decatenated kDNA
Linear Linearized kDNA














7.1 The DNA replication apparatus during gametocytogenesis
Gametocyte maturation in P. falciparum takes a relatively prolonged period of 8 to
10 days in vivo and 14 to 17 days in vitro (Smalley, 1977; Carter and Beach, 1978).
During this time, gametocytes appear to be metabolically inactive, relative to asexual
parasites, with the only outward sign of activity being the change in their shape
caused by the assembly and loss of components of their cytoskeleton (Sinden and
Smalley, 1979). Studies on DNA synthesis in P. falciparum gametocytes have
shown that a significant amount of DNA is synthesised at the onset of
gametocytogenesis with the DNA content increasing to about 1.8c most likely as a
result of amplification of specific genes rather than duplication of the whole genome
(Janse et al., 1986a).
Several genes involved in P. falciparum DNA replication have been isolated and their
stage-specific expression during the intraerythrocytic asexual cycle analysed.
PfRFCl, PfRFC2, PfRJFC3 (Douglas, J, 1999), PfPCNA (Kilbey et al., 1993),
PfDNA POLS (Ridley et al., 1991; Horrocks et al, 1996), PfTOPO I (Tosh and
Kilbey, 1995; Tosh et al., 1999) and PfTOPO II (Cheesman et al., 1994; Cheesman et
al., 1998) are all expressed in the late trophozoite stages of P. falciparum. The same
studies have also shown that the corresponding proteins encoded by these genes are
present in trophozoites and schizonts of P. falciparum. It is in trophozoites that
DNA replication starts (Gritzmacher and Reese, 1984, Inselburg and Banyal, 1984)
and it is to be expected that DNA replication proteins arid their gene transcripts are
present at this stage in the asexual parasite cycle.
As noted earlier, for much of their development, gametocytes show little evidence of
DNA synthesis once an initial incomplete duplication has taken place during the
formation of stage I gametocytes. It is only after activation of the mature stage V
gametocytes that DNA replication resumes at a rapid pace with three rounds of
replication completed in 10 minutes. There are two points to make at this stage.
First, the rapid synthesis of DNA only takes place in the male gametocytes
(microgametocytes) so as to provide for eight haploid microgametes. In addition,
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microgametocytes account for only 20% of the total gametocyte population, the rest
being female gametocytes (macrogametocytes). Because it is not possible, at present,
to apply methods such as Western blotting or northern analysis selectively to male
gametocytes, many changes in the levels of replication proteins are bound to be
masked by the presence of large numbers of female gametocytes.
Secondly, the changes in protein levels and/or activity are not by themselves likely be
the determining factors in initiating DNA replication. Other intracellular signalling
pathways, such as protein kinase cascades, that have been shown in other eukaryotes
to be responsible for the transduction of extracellular stimuli to the nucleus and
regulate cell proliferation and/or differentiation may play an important role P.
falciparum DNA replication. Indeed, Pfmap-2, a homologue of the mitogen-activated
protein kinase (MAPK), has been identified in P. falciparum gametocytes and is
thought to be responsible for maintaining the gametocyte in a non-replicative state
while it matures in the vertebrate host (Dorin et al., 1999). It is certain, however,
that DNA synthesis requires the active participation of the replication proteins
studied here and it has been the object of this work to assess whether they and/or
their cognate transcripts are present at all times, or only when DNA is being
synthesised. Important also is the need to establish whether the proteins, when
present, are active. It is, unfortunately, impossible at present to assay for the
activity of most of the DNA replication proteins since they function as a
multicomponent system and not many of the components have been isolated or
expressed in a functional form. It has however been possible to assay for the
PfTopol (Tosh et al., 1999), PfTopoII (Cheesman et al., 1998) and primase activity
(Prasartkaew et al., 1996).
The immunofluorescence results presented in this study showed that PfRfcl, PfRfc2,
PfRfc3, PfPcna and PfTopo II are present throughout gametocytogenesis. All five
proteins appear to be expressed at high level and are also localised to the nucleus
during early gametocytogenesis, that is, in stage I and II gametocytes. However,
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progression through stage III, IV and V lead to differing expression levels and changes
to the localisation of these DNA replication proteins.
During eukaryotic DNA replication, RFC functions as a complex of five proteins
(Hubscher et al., 1996), meaning all the five proteins have to be present during the
active synthesis of DNA. In this study, it was observed that PfRfcl levels appears
to be significantly higher in stage I and stage V gametocytes while PfRfc2 and PfRfc3
levels are significant only in stage I gametocytes compared to the other gametocyte
developmental stages. The presence of all three PfRfc proteins in the nuclear region
and at significantly higher levels in stage I gametocytes than in the rest of the
gametocyte stages suggests that DNA synthesis is likely to or has just taken place.
Indeed, this is consistent with the findings in earlier studies that showed that a
significant amount ofDNA is synthesised at the onset of gametocytogenesis, prior to
the formation of stage I gametocytes (Janse et al., 1986a:88). In addition, PfPcna and
PfTopoII levels also appeared to be significantly higher in stage I and V gametocytes.
Therefore these proteins are most likely actively aiding in the synthesis of DNA in
young stage I gametocytes.
In the more mature stages III and IV gametocytes, PfRfcl, PfRfc2, PfRfc3, PfPcna,
and PfTopo II proteins, though mainly present within the nuclear region, appear to
be at lower levels and also present within the cytoplasm. One way of reducing the
rate ofDNA replication may involve inactivating one or several of its components or
by disassembling its components and translocating them from the nucleus, where
DNA replication takes place, to the cytoplasm. This may, in part, be why PfRfcl,
PfRfc2, PfRfc3, PfPcna, and PfTopo II proteins appear to be evenly distributed
throughout the cytoplasm of stage IV gametocytes in contrast to their predominant
nuclear localisation observed in stage I and to some extent in stage II gametocytes and
then later on in stage V gametocytes. Compared to stages III and IV, gametocytes at
stage V of development, appear to have higher levels, of PfRfcl, PfRfc3, PfPcna, and
PfTopo II which are primarily located within the nuclear region, implying that stage
V gametocytes are putting in place the DNA replication apparatus in readiness for
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the rapid and repeated DNA replication that is set to occur during gametogenesis
following activation. However, the low levels of PfRfc2 and its distinct absence from
the nuclear region of stage V gametocytes suggests that DNA synthesis is unlikely to
be taking place. The sub-cellular localisation of components of the DNA replication
apparatus of may therefore be one of the factors influencing DNA replication during
gametocytogenesis and by extension during gametogenesis in P. falciparum.
7.2 The DNA replication apparatus during gametogenesis
Gametogenesis is a period of rapid cell division of the mature intraerythrocytic
microgametocyte (male gametocyte) which occurs when it passes from the
mammalian host to the mosquito gut. It leads to the formation of several
microgametes (male gametes) (Sinden et al., 1978). Gametogenesis involves the
simultaneous activation of several, apparently independent, cellular events, namely
the disruption of the host cell membrane, release of the parasite, the reorganization of
the cytoplasmic structures involved in the formation of the male gametes, and lastly
the rapid and repeated replication of the genome of the male gametocyte to provide
eight gametes (Alano and Carter, 1990). The latter requires the replication of the
entire parasite genome three times within ten to fifteen minutes at most (Janse et
al., 1986b). The speed of replication in gametocytes contrasts greatly with that in
asexual parasites, and it has been suggested that in order to achieve this rapid and
repeated DNA replication during gametogenesis, approximately 1300 replication
forks are activated simultaneously in the mature gametocytes at the onset of
gametogenesis (Janse and Mons, 1987). The induction of so many independent
replication forks at the onset of microgametogenesis itself not only suggests that
mature microgametocytes are heavily precommitted to the rapid production of male
gametes in the mosquito midgut but also that the induction mechanism is highly
amplified within the parasite nucleus. This makes the mature gametocyte an ideal cell
in which to study the mechanism ofDNA replication.
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In this study, western analysis, carried out during gametogenesis, showed that some
components of the DNA replication apparatus of P. falciparum namely, PfRfcl,
PfRfc3, PfPcna and PfTopoII remained at constant levels following activation. This
may suggest that the rapid and repeated DNA synthesis that takes place during the
first ten minutes of gametogenesis, does so without the requirement of significant
additional synthesis of PfRfcl, PfRfc3, PfPcna, and PfTopo II proteins. However,
Western analysis showed that the level of PfRfc2 increased immediately after
activation and then gradually decreased as gametogenesis progressed. In the IFA
results shown earlier, PfRfc2 was seen to be distinctly absent from the nucleus of
stage V gametocytes. Taken together, the IFA and Western analysis results on the
expression patterns of PfRfc2 in mature gametocytes before and after activation,
appear to be different from that of the other DNA replication proteins tested and in
particular, that of PfRfcl and PfRfc3. It is therefore possible that PfRfc2 may be
one of the components of the DNA replication apparatus that is actively synthesised
and transported to the nucleus following activation ofmature gametocytes. This may
suggest that some level of protein synthesis does take place during gametogenesis.
Indeed, the use of metabolic inhibitors of protein synthesis, specifically those
affecting peptide elongation, like emetine, were found to effectively inhibit
exflagellation in P. yoelii nigeriensis (Toye et al., 1977; Janse et al., 1986b).
However, further experiments, such as the in situ detection of PfRfc2 during
gametogenesis, require to be carried out in order to get to a better understanding of the
role ofPfRfc2 during gametogenesis.
Transcription of these DNA replication genes during gametogenesis appears to be
very low and hardly detectable by northern analysis. However, the more sensitive
RT-PCR analysis was able to detect transcripts of PfRFC2, PfRFC3, PfPCNA,
PfDNA POLS and PfTOPO I in mature inactivated gametocytes. These transcripts
remained detectable even after activation. However, messages for PfRFCl and
PfTOPO II were not detected, by RT-PCR, in either mature inactivated gametocytes
or after activation. At this point, it is not possible to determine whether transient
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transcription and translation of PfRFC2, PfRFC3, PfPCNA, PfDNA POL8 and
PfTOPO I does take place during gametogenesis especially due to the very low levels
of transcripts detected by northern analysis. However, earlier studies have shown
that actinomycin D, an inhibitor of DNA-directed RNA synthesis in both
prokaryotes and eukaryotes, partially inhibited exflagellation in P. yoelii nigeriensis.
This was seen to suggest that the possibility that transcription does occur to some
extent during microgametogenesis and requires de novo synthesis of mRNA. Due to
this partial inhibitory effect of actinomycin D on exflagellation, the existence of a
long-lived mRNA, presynthesised in the maturing gametocyte and translated only at
the onset of exflagellation was not excluded (Toye et al., 1977).
The inability to separate male from female gametocytes in order to carry out protein
and RNA analysis makes it difficult to track down any changes that might occur in
the replication proteins and their cognate transcripts during gametogenesis. This is
further complicated by the fact that only the microgametocytes undergo DNA
replication and account for only 20% of the gametocyte population. In addition, at
any one time not all the microgametocytes will activate upon induction of
gametogenesis due to several reasons among them immaturity.
7.3 Gametogenesis and Topoisomerase II activity
The presence of the components of the DNA replication machinery at stage of the
parasite development does not directly imply activity. One or more of the
components of the DNA replication apparatus may require to be activated, say by
postranslational modification or by phosphorylation. Indeed, the extent of
phosphorylation of the mammalian Topol has been shown to vary throughout the
cell cycle (Pommier et al., 1990) and it has been suggested that phosphorylation of
TopoII influences activity (Ackerman et al., 1985). Of the components of the DNA
replication apparatus, PfTopol and PfTopoII activity can be assayed in vitro.
Recent studies have shown that PfTopoII activity was highest in schizont protein
extracts (Cheesman et al., 1998). Topoisomerase II activity was assayed in
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gametocyte protein extracts prepared before activation and during the first 5 minutes
of gametogenesis. Decatenation activity assays showed that topoisomerase II
activity, though present in mature inactivated gametocytes, progressively increased
during gametogenesis. The residual decatenation activity observed in inactivated
gametocytes may have been due to some gametocytes having activated during the
purification procedure. The possibility that asexual parasites contributed to this
residual decatenation activity was ruled out as a combination of GluNAc-treatment
and Percoll gradient centrifugation was found to completely eliminate viable asexual
parasites from gametocyte preparations. Ideally, this experiment should have been
carried out using serial dilution of gametocyte extracts and stopped at several shorter
time points. In that way, the levels of TopoII activity within each extract would
have been more clearly defined. However, larger amounts of gametocyte extracts
would have been required. Western analysis of the same gametocyte protein extract
showed no significant increase in the level of PfTopoII during this period. The
discovery of PfTopoII activity during gametogenesis is consistent with the fact that
rapid DNA replication that takes place during gametogenesis would require the
functions of TopoII in separating the DNA strands.
7.4 Exflagellation and DNA replication
Exflagellation, the emergence of male microgametes, marks the end of gametogenesis
(Sinden et al., 1978). Gametocytes grown entirely in CCMS upon reaching maturity,
activate, that is lose their sickle-shape and 'round-up', and then progress on to
exflagellate when resuspended in gametogenesis stimulating medium (GSM).
However, in this study it was observed that gametocytes grown entirely in CCMA,
activated but did not progress on to exflagellate when resuspended in GSM. Both
activated gametocytes from CCMA- and CCMS-maintained cultures were
indistinguishable, when viewed through a microscope, and exhibited the characteristic
internal violent activity. It was observed, in the course of this study, that the
capacity ofCCMA-grown mature gametocytes to exflagellate could be regained by an
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overnight incubation in CCMS. This implies that there are factors in serum that are
critical for exflagellation, and that these factors may not be present in AlbuMaxII.
With regard to DNA synthesis and the capability to exflagellate or not, the status of
the DNA replication apparatus was analysed in the period prior to the onset of
exflagellation; exflagellation leads to the disruption of the male 'gametocyte', hence
the loss ofmost of its cellular contents (Sinden et al., 1978). The results obtained in
this study appear to show that no significant difference, with regard to the presence
of DNA replication proteins or their gene transcripts, between gametocytes that do
activate only or those that activate and also have the capacity to exflagellate. This
suggests that DNA replication and exflagellation may be, to some extent, totally
independent events.
7.5 In situ hybridisation
In situ hybridisation (ISH) is a powerful technique, which enables the study of gene
expression at the single-cell-level. ISH makes it possible to study gene expression in
unsynchronised cell populations. P. falciparum is notoriously difficult to maintain in
synchronised growth for more than 48 hours and in vitro cultures become
progressively unsynchronised with time. Synchronised cultures of P. falciparum are
routinely achieved by eliminating the mature asexual forms, trophoziotes and
schizonts, by sorbitol treatment (Lambros and Vandenberg, 1979) or by the
separation of the mature forms from the ring-forms by gelatin flotation (Ponnudurai
et al., 1986). The use of northern analysis to determine stage-specific differential
gene expression during asexual or sexual differentiation in P. falciparum relies heavily
on the need to have tightly synchronised parasite cultures at high parasitemia. This
is laborious and expensive to achieve but, however, possible when dealing with
asexual parasites. Gametocytes, however, present a more difficult situation.
Conversion to gametocytes only starts when healthy asexual parasites cultures
undergo some form of stress brought about by several factors, among them, high
parasite densities (Carter and Miller, 1979). Even then, only a maximum of 20-30%
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of the parasites start to differentiate into gametocytes. Unlike asexual parasites,
gametocytes do not replicate and therefore the number of gametocytes only increase,
in culture, as a result of further conversion of some asexual parasites. The periodic
conversion of asexual parasites into gametocyte further creates a culture composed of
gametocytes at different stages of development. The low gametocyte yields due to
poor and unpredictable conversion rates, combined with the continuous presence of
asexual parasites within gametocyte cultures makes the study of gene expression in
gametocytes per se, rather difficult especially during gametocyte development..
Therefore, the study of transient gene expression during gametocytogenesis by the
use of northern analysis would be at best, difficult, especially if the simultaneous
expression of several genes is to be sought during gametocyte development.
ISH is difficult to set-up but once the right conditions are established, the
simultaneous expression of several genes in a population of mixed cells should be
readily determined. It is in light of this that an attempt was made to establish a
working protocol to use in the study of gene expression of in P. falciparum by the
use of RNA in situ hybridisation. As a start, fluorescein-labelled gene fragments of
PfDNA replication genes were used to probe paraformaldehyde-fixed thin films of
asexual parasites. Probes against PfRFCl, PfRFC2, PfPCNA, PfDNA POL8,
PfTOPO I and PfTOPO II all showed pockets of distinct fluorescence mainly on the
peripherals of young and mature schizonts away from the nuclear region stained by
DAPI. However, PfRFC3 showed fluorescence located within the DAPI-stained
nuclear region. During gene expression, DNA is transcribed into heterogeneous
nuclear RNA (hnRNA), hnRNA is processed to produce mature mRNA via the
spliceosomes, mRNA is transported into the cytoplasm where it is translated into
protein. It is therefore possible to detect fluorescence within the nuclear region as a
result of hybridisation of the probe to hnRNA. The detection of hnRNA confirms
that gene expression is switched on or up regulated. In this study, the fluorescence
primarily appeared to emanate from the region outside the nucleus
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Shorter probes gave very low fluorescence and this was attributed to the presence of
fewer detectable reporter molecules, in this case fluorescein. Short probes are more
prone to loss during the washing steps and this would also contribute to the low
fluorescence observed. Though longer probes are easier to detect, especially by the
direct method, they suffer from the risk of non-specific hybridisation and more
stringent washes are required. In this study, the direct in situ detection method used
had it advantages and disadvantages. Although RNA is inherently more prone to
degradation that DNA, it is usually more abundant than its homologous DNA
sequence and is, therefore, easier to detect. As this was the first time this was being
attempted, the need for a quick detection method was preferred. The ease of probe
preparation using fluorescein-PCR labelling meant that probes of different lengths
could be generated tested. However, most of the steps from the application of the
probe onwards had to be carried out in the dark so as to preserve the fluorescence of
the fluorescein-labelled probes. Fluorescence quickly faded away during examination
on a fluorescent microscope even in the presence of antifade reagents such as
DABCO.
FISH experiments were also carried out on nuclease-treated thin parasite films using
PfTOPO I probes. Fluorescence was observed in DNase-treated thin smears even
when DAPI staining confirmed the complete degradation of gDNA. This would
imply that the fluorescence was possibly the result of probe hybridization to
mRNA. However, additional controls are required, such as the RNase-treatment of
thin films prior to FISH experiments. The absence of a nuclear staining by DAPI
following DNase-treatment made it difficult to distinguish the different stages of the
parasites.
There are very few studies reported that have used ISH to study gene expression in
Plasmodium. In P. berghei, the expression of Pbs21 mRNA, a gene encoding a
parasite surface antigen, was shown by ISH, to be expressed in a sex-specific manner
exclusively in the female gametocyte (Thompson and Sinden, 1994). ISH has also
been used to show the sexual-stage-specific mRNA expression of Pfll P. falciparum
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(Baker et al., 1995). In both these studies, riboprobes were used for ISH and the
signal from gDNA was distinguished from that of from the mRNA by the use of
sense and antisense probes.
7.6 Conclusion
1. Plasmodium falciparum DNA replication proteins, PfRfcl, PfRfc2, PfRfc3,
PfPcna and PfTopoII, are present in gametocytes throughout gametocytogenesis
despite the fact that DNA synthesis only takes place at the onset of
gametocytogenesis.
2. During gametocytogenesis, PfRfcl, PfRfc3, PfPcna and PfTopoII are
predominantly located in the nuclear region and at higher levels in stage I and V
gametocytes.
3. PfRfc2 is distinctly absent from the nucleus of stage V gametocytes and is instead
predominantly located in the cytoplasm. PfRfc2 is present and at higher levels
within the nuclear region of stage I gametocytes.
4. During gametogenesis, the levels of PfRfcl, PfRfc3, PfPcna and PfTopoII remain
markedly unchanged whereas PfRfc2 levels increase markedly at the onset of
gametogenesis and then gradually decrease as gametogenesis progresses.
5. Topoisomerase II activity is present in mature gametocytes but increases




1. In general, only one in eight gametocytes is male and in addition, only the male
gametocyte undergoes DNA replication during gametogenesis. It would therefore
be worthwhile to find a way in which male and female gametocytes can be
separated or clearly distinguished from one another. One way would be to
include gametocyte sex-specific markers during the in situ detection of the
components of the DNA replication apparatus in malaria gametocytes.
2. PfRfc2 showed a unique expression pattern from that of the other DNA
replication proteins and in particular PfRfcl and PfRfc3, before and during
gametogenesis. It would be interesting to carry out further studies focussing
specifically on PfRfc2 in order to get to a better understanding of its role during
gametogenesis.
3. The results of this study also showed that Topoisomerase II activity increases
during gametogenesis while the PfTopo II protein levels remain unchanged. Other
studies have shown that topoisomerase II activity is influenced by
phosphorylation. It would be interesting to check whether the phosphorylation
state of PfTopoII changes upon activation of mature gametocytes. Identification
of the protein kinase(s) responsible would also be worth looking into.
4. It would also be interesting to link DNA replication in mature gametocytes to the
known eukaryotic cell cycle by looking into the presence and activity level of
cyclins and cyclin-dependent kinases (CDK) respectively, before and after
gametogenesis. Establishing the status of the origin of replication complex would
also shed more light on the how the mature gametocyte is able to set off into a
rapid and repeated replication of its genome thrice in less than ten minutes.
5. The promoter activities of most of the genes involved P. falciparum have been
determined during the asexual cycle. It would also be interesting to determine
whether the promoters of all the seven genes considered in this study are active
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